recently appreciated. Two ongoing studies in our laboratories, which are exploring neural substrates associated with neuroplasticity in spinal Fibroblast growth factors (FGF) 2, 8, and 18 are critical for neorespiratory and locomotor function after cervical SCI, will be discortical development. FGF2 has been implicated in regulating cortical cussed.
Despite considerable appreciation for many forms of plasticity as-*Cellular Neurobiology Research Branch, Intramural Research sociated with neurological disease and trauma, relatively few efforts Program, National Institute on Drug Abuse, National Institutes have been directed at interfacing therapeutic interventions with identiof Health, Department of Health and Human Services, fied natural repair mechanisms. This is especially true for spinal cord Baltimore, MD, USA injury (SCI) as the spinal cord's neuroplastic potential has only been †ScienCell Research Laboratories, San Diego, CA, USA recently appreciated. Two ongoing studies in our laboratories, which are exploring neural substrates associated with neuroplasticity in spinal Fibroblast growth factors (FGF) 2, 8, and 18 are critical for neorespiratory and locomotor function after cervical SCI, will be discortical development. FGF2 has been implicated in regulating cortical cussed.
neurogenesis, whereas the FGF8 subfamily has been reported to be Considerable interest has recently centered upon the role of longinvolved in the positional identity of neocortical neurons. FGF2 prodistance projecting interneurons in mediating functional improvement motes cortical differentiation of cultured neural stem cells, and may after SCI; however, much less is known about the neuroplastic potenbe useful for the application of neural stem cells to both basic research tial(s) of the relatively short, intra-or intersegmental interneurons that and cell-based therapeutics. In contrast, effects of other members of provide the majority of inputs to motoneurons at cervical and lumbar the FGF family, including FGF8 and FGF18, on differentiation of culenlargement levels. We are exploring the role of spinal interneurons tured cortical neural progenitor cells have not been extensively examin plasticity associated with a well-documented form of spontaneous ined. We presently examined the effects of combinations of FGF8 and recovery following C2 hemisection (HMx) and denervation of inspira-FGF18 with FGF2 on the fate of human neural progenitor cells tory drive to the ipsilateral phrenic motoneuron (PhMN) pool. The (hNPC) obtained from ϳ20-week human fetal cerebral cortex. Differ-"crossed phrenic phenomenon" can be observed after C2 HMx and is entiation was induced by priming neurospheres with FGF2 alone, or characterized by a gradual, though incomplete, spontaneous recovery with FGF2 in combination with FGF8, or FGF8 plus FGF18, for 8 of ipsilateral PhMN output. Monosynaptic projections from intact, days. FGF(s) were then replaced with BDNF and NT3 for 2 more contralateral inspiratory drive axons have been proposed to be the weeks. Immunocytochemical analysis showed that addition of FGF8 main synaptic substrate associated with the CPP because interneurons to FGF2 significantly increased the percentage of cells undergoing premotor to the PhMN pool in the rat have not been conclusively neuronal differentiation from 24% to 38% as measured by MAP-2identified. However, using transynaptic pseudorabies virus (PRV) tracpositive immunostaining, or from 34% to 50% as measured by Tuj-1ing, we have observed a population of neurons in the normal and inpositive immunostaining. Addition of FGF18 to FGF2 plus FGF8 did jured cervical (C3-C6) spinal cord that are second order to infected not further potentiate neuronal differentiation. The differentiated neu-PhMN neurons following hemidiaphragm PRV delivery (see also Abrons were immunoreactive for glutamate (71 ± 3%) and GABA (84 ± stract by Lane et al.) . Based on their relative cell size, Rexed laminar 2%), but not for TH (0.8 ± 0.3%), ChAT (0%), or 5-HT (0%). In addilocation, and bilateral distribution, many of these neurons are consistion, these hNPC-derived neurons were electrically excitable and retent with a commissural, interneuronal phenotype. Our findings thus sponded to glutamate and GABA. Therefore, FGF8 potentiates glutaraise the possibility these interneurons may play a role in mediating matergic and GABAergic neuronal differentiation of cultured human expression of respiratory changes following C2 HMx. neural cortical progenitor cells, and thus may expand the possibilities Another interesting feature of spinal neuroplasticity has been refor using hNPC for both basic research and therapeutic applications. vealed in a separate investigation assessing the walking potential of a Research supported by the IRP of NIDA, NIH, DHHS. nonambulatory child with a severe, stable, low cervical spinal cord injury who was deemed permanently wheelchair dependent. Sixteen Human Umbilical Cord Blood Cells Increase Proliferation months after injury, the child was enrolled in our locomotor training of Endogenous Progenitor Cells in the Granule Cell Layer (LT) program. After 4 weeks of LT, with relatively no response, of Aged Rats flexor-specific sensory input was incorporated, and he took his first voluntary steps. Although the child lacks isolated voluntary lower ex-A. D. Bachstetter,* A. E. Willing,* † M. Cole, † C. Hudson, ‡ tremity movement, he has recovered the ability to initiate stepping and P. R. Sanberg,* † P. C. Bickford,* † ‡ and C. Gemma † ‡ ambulate independently within the community using a rolling walker. The absence of isolated voluntary lower extremity movements together *Department of Molecular Pharmacology and Physiology, University with his stepping characteristics suggests the absence of corticospinal projections below the site of injury. We speculate that his walking of South Florida, Tampa, FL, USA ability may be due to activity-based recruitment of the reticulospinal †Department of Neurosurgery, Center of Excellence for Aging system, which in lower vertebrates is capable of activating the spinal and Brain Repair, University of South Florida, Tampa, FL, USA pattern generators. Thus, it may be that evolutionarily primitive path- ‡James A. Haley V.A. Hospital, Research Service, Tampa, FL, USA ways exist in the human spinal cord that may serve as important therapeutic substrates for rehabilitation and various repair approaches fol-Neurogenesis continues to occur throughout life predominantly in the subgranular zone (SGZ) of the dentate gyrus in the hippocampal lowing SCI. 313 314 ABSTRACTS formation and in the subventricular zone (SVZ). Adult hippocampal when cografted with LC tissue. When analyzing the LC grafts, the presence of VM neither enhanced the volume of the LC grafts nor neurogenesis dramatically decreases with increasing aging, and it has been reported that such decrease is mostly related to a decline in pro-the number of TH/DBH-positive neurons. When giving the animals blueberry diet, the number of TH-positive neurons was increased in liferative activity rather than alteration of the survival of the newborn neurons. Impoverishment of the microenvironment of the aged brain, VM single grafts compared with the controls and the number of Iba-1-positive microglia was significantly decreased. The addition of blue-particularly a reduction in the availability of trophic factors and increased inflammation, may be involved in the age-related decrease in berry diet did not influence the number of TH/DBH-positive neurons or Iba-1-positive microglia in LC single grafts. In conclusion, this hippocampal neurogenesis. Saneron's proprietary fraction (U-CORD-CELL TM ) of human umbilical cord blood cells (HUCBC) is a mononu-study implies that the presence of LC noradrenergic neurons enhances VM dopamine neuronal survival in terms of increased number of neu-clear fraction that contains a number of cell types, including B cells and T cells, as well as hematopoietic, mesenchymal, and endothelial rons and decreased number of microglia, whereas there is no beneficial effect on LC when VM is present. Furthermore, animals given an anti-progenitor cells. Previously, it has been shown that intravenous injection is as efficacious as intracranial transplantation in producing the oxidant-enriched diet demonstrate enhanced survival of VM dopamine neurons as well as fewer microglia within the VM tissue. neuroprotective effects of HUCBC, including increased neurogenesis in the aged hippocampus. Neurogenesis can be increased by either an increase in proliferation of the endogenous progenitor cells or in-GDNF Receptors as a Drug Target for Neural Repair creased survival of the proliferating cells. The goals of the present study were (1) to determine if the HUCBC-induced increase in hippocampal neurogenesis is a result of an increase in proliferation of the M. M. Bespalov,* C. Hetenyi, † S. Tumova, ‡ A. Hienola, ‡ Y. Sidorova,* H. Rauvala, ‡ M. Karelson, † and M. Saarma* endogenous stem cells in the hippocampus, and (2) to establish the time course of HUCBC effect on cell proliferation. To this end, aged rats (20 months: n = 24) and young rats (3 months: n = 24) were ran-*Institute of Biotechnology, University of Helsinki, Helsinki, Finland domly selected to receive a single intravenous injection of either 10 6 †Department of Chemistry, University of Tartu, Tartu, Estonia HUCBC (n = 12) or media (n = 12). At day 1 or day 14, each rat ‡Neuroscience Center, University of Helsinki, Helsinki, Finland received two injections of bromodeoxyuridine (BrdU, 50 mg/kg) spaced 8 h apart and the rats were then sacrificed the following day.
Glial cell-line derived neurotrophic factor (GDNF) family of li-Unbiased stereology, using the optical fractionator, was utilized to esgands (GFL) regulates the development and maintenance of the nertimate the number of BrdU+ cells in the granule cell layer. The results vous system, kidney, and spermatogenesis. The family consists of demonstrate that a single intravenous injection of HUCBC in aged rats GDNF, neurturin, artemin, and persephin. Importantly, GDNF supcan significantly increase proliferation 1 day following the cell delivports the survival of midbrain dopaminergic neurons and spinal motorery. Furthermore, the effect of HUCBC on proliferation is maintained neurons. Therefore, it has a potential in treatment of Parkinson's dis-15 days following the injection of HUCB, showing that the effects of ease and amyotrophic lateral sclerosis (ALS). Two clinical trials of HUCBC on proliferation are long lasting. The increase in neurogenesis GDNF for Parkinson's disease were positive. However, Amgen's clinshown previously might be a result of this increased proliferation, as ical trial failed to show a clear clinical benefit of GDNF. GDNF also a portion of the proliferating cells would be fated to become neurons, stimulates dopamine production in healthy animals and thus may be but an additional effect on survival has not been ruled out. These reconsidered for the treatment of depression. Neurturin has also recently sults suggest that the use of HUCBC as a potential therapeutic agent been reported to be beneficial in one Parkinson's disease clinical trial may provide a prolonged benefit to the aged brain.
(Ceregen, Inc.). Artemin is currently in clinical trial for the treatment Supported by a grant to AEW from NIH (R01AG020927). P.C.B.
of neuropathic pain (Biogen, Inc.) . Persephin may hold a promise for and A.E.W. are consultants to and P.R.S. is cofounder of Saneron stroke treatment. All GFLs signal via receptor tyrosine kinase RET. CCEL Therapeutics.
GFLs are unable to bind RET directly but require a membrane-anchored co-receptor. Alternative receptor for GFLs may be a neural cell adhesion molecule NCAM, which regulates the migration of neuronal pre-Locus Coeruleus and Blueberry-Enriched Diet Improve Survival cursors in rostral migratory stream. We have identified a new receptor of Dopamine Neurons and Reduce Microglia in Ventral for GDNF, neurturin, and artemin. In the nervous system it is a he-Mesencephalon. An In Oculo Grafting Study paran sulfate proteoglycan syndecan-3. Syndecan-1 is GDNF co-receptor in developing kidney. GDNF, neurturin, and artemin bind to the he-E. Berglöf,* P. C. Bickford, † and I. Strömberg* paran sulfate moiety of the proteoglycan, triggering Src family kinases activation. This leads to neuritogenesis and neuronal migration. In par-*Department of Integrative Medical Biology, Umeå University, ticular, GABAergic neuroblasts migrate towards GDNF in the synde-Umeå, Sweden can-3-dependent manner. Mice lacking syndecan-3 have significantly less cortical GABAergic neurons. This phenotype is shared by GDNF †Department of Neurosurgery, University of South Florida, Tampa, heterozygous animals, further suggesting physiologically relevant FL, USA GDNF interaction with syndecan-3. The fact that in nervous system GDNF binds with high affinity (K d = 10 nM) to syndecan-3 suggests It is well established that both the dopaminergic neurons in the substantia nigra and the noradrenergic neurons in the locus coeruleus that the bioavailability of injected GDNF will be very limited. Thus, to increase to potency of GDNF as a pharmacological agent we gener-(LC) undergo degeneration in Parkinson's disease (PD). In fact, the loss of noradrenergic neurons is more pronounced and thus suggests ated the heparin-binding-deficient GDNF mutant, which does not bind to heparin but potently activates RET and rescues dopaminergic neu-that PD might be initiated by noradrenergic degeneration. Additionally, it has been shown that an antioxidant-enriched diet is beneficial rons. GFLs have long been established as attractive agents for the treatment of chronic neurological diseases. However, as polypeptides for dopaminergic regeneration in animal models of PD. Therefore, this study was undertaken to analyze the interactions between LC and sub-their pharmacological usage is limited. They are unable to pass the blood-brain barrier. GFLs have several alternative receptors possibly stantia nigra, as well as to evaluate the effects of an antioxidantenriched (blueberry) diet on fetal ventral mesencephalon (VM), by us-leading to multiple side effects, and GFLs interact with heparan sulfates, the components of the extracellular matrix. Small molecule GFL ing the intraocular grafting model. Isolated tissue pieces from fetal VM and LC were grafted either as single grafts or as VM + LC co-mimetics are an excellent alternative to the protein-based therapies. However, the small molecule agonists' development for multicompo-grafts, and analyzed 2 months postgrafting. Blueberry diet was given 1 month prior to grafting and treatment continued throughout the ex-nent receptor tyrosine kinase complex was thought to be unfeasible. We now by rational design combined with screening techniques dem-perimental time. Evaluation of the grafts revealed that when cografting VM with LC, a significant increase in graft volume as well as a signifi-onstrate that a number of small molecules (less than 500 Da) can activate GFL receptor complexes. These compounds may be used as a cant increase in the number of tyrosine hydroxylase (TH)-positive neurons was observed within the VM. Additionally, the number of micro-lead for the development of medicines for the treatment of Parkinson's disease, ALS, chronic pain, and depression. glia (Iba-1 positive) within the VM tissue was significantly decreased BBB monolayers using an Electric Cell-Substrate Impedance Sensor have potent effects on midbrain dopamine (DA) neurons. In addition, both trophic factors have neuroprotective and neurorestorative effects (ECIS) system. MPP+ killed SHS5Y5 cells in a dose-dependent fashion, but conditioned media from these cultures did not affect HBMEC for DA neurons in models of Parkinson's disease. The goal of the present study was to compare the effects of GDNF and NTN on the resistance, confirming the in vivo studies where DA neuron death did not appear to be directly involved with the BBB dysfunction. Condi-nigrostriatal DA system of normal rats by determining how a single injection of GDNF or NTN affects striatal DA release and striatal and tioned media from saline and LPS-activated CRL-1718 astrocytes both caused significant but equivalent increases in resistance, suggesting nigral tissue levels of DA. Male Fischer-344 rats were given a single intranigral injection of vehicle or 5 µg GDNF or 5 µg NTN. Three that soluble factors from astrocytes increase HBMEC resistance, but astrocyte activation did not alter BBB dysfunction. In contrast, condi-weeks later microdialysis experiments were conducted to measure basal levels of DA and its metabolites, and potassium-and amphet-tioned media from LPS-treated BV-2 microglial cells produced dosedependent reductions in resistance whereas direct treatment of the amine-evoked overflow of DA from both the right and left striata. Basal extracellular levels of striatal DA were not affected by either HBMEC with LPS had no effect. Taken together, these data sets suggest that products from activated microglia are responsible for the the GDNF or NTN treatments. However, both trophic factors led to decreases in basal levels of DOPAC on the injected side. NTN also leakage in the BBB observed following exposure to DA neurotoxins.
Supported by NINDS NS045316 and the Richard Nopar Fund. led to a significant decrease in HVA on the injected side. Potassiumevoked overflow of striatal DA was unaffected by the intranigral injection of either GDNF or NTN. Amphetamine-evoked overflow of stria-Trophic Factors Promote Reinnervation of Adult Rat Skeletal tal DA was decreased by approximately 20% in both the GDNF-and
Muscle by Embryonic Ventral Spinal Cord Cells Transplanted
NTN-treated animals. Postmortem levels of DA in the striatum were Into Peripheral Nerve decreased by approximately 30% in the ipsilateral side of the brain compared to the contralateral side following both GDNF and NTN G. T. B. Casella, K. Hemstapat, V. W. Almeida, R. M. Grumbles, injection. Both trophic factors led to increases of about 100% in postand C. K. Thomas mortem tissue levels of DA in the substantia nigra. Thus, GDNF and NTN, when administered into the substantia nigra at equal doses, lead The Miami Project to Cure Paralysis, University of Miami Miller to almost identical changes in evoked overflow of DA from the stria-School of Medicine, Lois Pope LIFE Center, Miami, FL, USA tum and in changes in tissue levels of DA in the nigrostriatal pathway. The similarities between the effects of GDNF and NTN suggest that Spinal cord trauma and neurodegenerative diseases (e.g., amyotroboth trophic factors may have similar efficacies for the treatment of phic lateral sclerosis) cause motoneurons within the spinal cord to die. neurodegenerative disorders involving dopaminergic dysfunction. Not only are the denervated muscle fibers paralyzed (not under volun-Supported in part by USPHS grant AG17963. tary control), they atrophy rapidly and progressively. Provision of embryonic ventral spinal cord neurons in the tibial nerve close to a denervated muscle restores some functional neuromuscular connections and is one way to reduce denervation-induced muscle atrophy (Thomas et Slowly Cycling Endogenous Stem/Progenitor Cells Can al., J. Neurophysiol. 84:591-595; 2000) . Survival of more motoneu-Regenerate the Young and Aged Rostral Migratory Stream rons and greater axon regeneration may improve muscle recovery fur-Following Antimitotic Treatment ther. The aim of the present study was to determine whether muscle reinnervation in adult Fischer rats was improved by transplantation of T. Chadashvili and D. A. Peterson embryonic neurons and a combination of factors known to be important for motoneuron survival. The sciatic nerve was sectioned to mimic Neural Repair and Neurogenesis Laboratory, Department of destruction of several motor pools. The proximal nerve stump was Neuroscience, The Chicago Medical School, Rosalind Franklin sewn into hip muscle to prevent reinnervation from the peripheral nervous system. After 1 week of nerve degeneration, 1 million embryonic University Med & Science, North Chicago, IL, USA day 14-15 (E14-15) ventral spinal cord cells (in Neurobasal medium supplemented with B-27 and antibiotics) were transplanted into the
The key characteristics of stem cells are their slow reentry into cell distal tibial nerve stump of adult Fischer rats with glial cell linecycle for self-renewal and by the multipotent lineage capacity of their derived neurotrophic factor, (GDNF, 10 ng/ml), hepatocyte growth daughter cells. The existence of stem cells in the adult subventricular factor (HGF, 10 ng/ml), and insulin-like growth factor (IGF-1, 50 ng/ zone (SVZ) has been demonstrated previously by the ability of slowly ml). One control group of rats received the cell transplant without cycling cells to survive sustained antimitotic killing of rapidly dividing factors whereas the other control group received no cells or factors. cells and to repopulate the SVZ. To determine if a similar population Ten weeks later, electromyographic activity (EMG) and force were of slowly cycling, multipotent cells exists in the RMS, we infused recorded from most medial gastrocnemius, lateral gastrocnemius, and cytosine arabinoside (AraC) or saline onto the surface of the brains of plantaris muscles in response to electrical stimulation of the transboth young (2 months) and aged (24 months) adult F344 rats for 7 plants. Whole muscle forces were generally stronger in rats that redays. For detection of proliferative history, injections of IdU were ceived transplants supplemented with trophic factors. Muscles, nerves, given over 1 week prior to the AraC infusion. Prelabeling with IdU and transplant were recovered and will be processed using immunohisidentified a population of cells, some of which would not cycle during tochemistry and histology. Preliminary analysis indicates that augmenthe period of AraC infusion and thus survive. CldU was given following tation of the transplant medium with a combination of trophic factors AraC just prior to sacrifice at time of pump removal or 2 days later. In facilitates establishment of functional reinnervation of skeletal muscle saline-infused animals, proliferating cells labeled with CldU in the SVZ in this neuron replacement model. and RMS did not differ from naive controls. Following AraC infusion, Funded by USPHS grant no CldU-positive cells were observed in SVZ or RMS, showing that Cure Paralysis.
antimitotic killing had been complete. However, by 2 days after AraC, CldU-positive cells were observed in both the SVZ and RMS, suggest-
Effects of Neurturin and GDNF on Striatal Dopamine Overflow
ing that both locations harbor populations of slowly cycling cells. IdU+ and Content in Normal Rats cells persisted in the RMS, indicating that this population was slowly cycling and slow or nonmigratory. Some cells contained both IdU and W. A. Cass and L. E. Peters CldU, providing an index of the subpopulation that underwent DNA replication between 9 and 16 days apart. Less than 10% of the IdU+ cells coexpressed CldU, indicating the cycling frequency of the majority Department of Anatomy and Neurobiology, University of Kentucky of IdU+ cells was greater than 2 weeks. Similarly, the majority of College of Medicine, Lexington, KY, USA CldU+ cells did not coexpress IdU, suggesting that this population pri-Glial cell line-derived neurotrophic factor (GDNF) and neurturin marily arose from an even more slowly cycling population that had last undergone DNA replication before the period of IdU administration. (NTN), another member of the GDNF family, have been shown to 318 ABSTRACTS These data support the idea that the RMS contains a resident population spinal cord. Spinal cord contusion injury was generated using NYU Impactor device, dropping a 10-g weight from 25-mm height at tho-of stem cells and that this population persists into old age.
Supported by NIH AG022555 to DAP. racic vertebrate level 10 (T10) in Sprague-Dawley rats. EGFP-NPCs expressing enhanced green fluorescent protein (EGFP) were transplanted 1 week postinjury. Animals were sacrificed 6 weeks after transplantation. Within the spinal cord, we found that EGFP-NPCs Trophic Effects of Human Umbilical Cord Blood Cells migrated up to 2 cm rostral and 1 cm caudal to the lesion/transplant on Neurons Harvested From Both Young and Aging Brain site, centered at T10. Nestin colocalized with EGFP+ cells in the spinal cord, but few expressed GFAP. To determine the neural progenitor N. Chen,* † S. Garbuzova-Davis,* †#** P. C. Bickford,* † § † † nature of the transplanted cells, we did immunocytochemical staining C. Davis Sanberg,** P. R. Sanberg,* † ‡ ¶** and A. E. Willing* † ‡ § for nestin (neuroepithelial marker), double cortin (Dcx-immature neuronal marker), NeuN (mature neurons), and glial fibrillary acidic pro-*Center of Excellence for Aging and Brain Repair, USF College tein (GFAP for astrocytes). We found that many EGFP+ transplanted of Medicine, Tampa 
Human umbilical cord blood (HUCB) contains multiple cell types
Aging and the Natural History of Parkinson's Disease including stem cells. We have previously shown that HUCB cells produce numerous factors including growth factors, cytokines, and neuro-T. J. Collier,* N. M. Kanaan,* and J. H. Kordower † trophic factors that may prevent neural decline or degeneration and promote repair/regeneration. In this study, we hypothesize that the fac-*Department of Neurology, University of Cincinnati, tors produced by HUCB cells are able to play a role of neuroprotection Cincinnati, OH, USA in neurons generation and development. To approach this goal, we †Department of Neurological Sciences, Rush University Medical cocultured Saneron's proprietary fraction (U-CORD-CELL TM ); a mononuclear fraction of cells derived from HUCB with neuronal cells Center, Chicago, IL, USA dissociated from the subventricular zone (SVZ), hippocampus, and cortex of 4-or 20-month-old rat brain for up to 21 days. With immu-Aging long has been acknowledged to be a risk factor for Parkinnocytochemistry, we found that few HUCB cells in coculture with son's disease (PD). However, the link between the two has usually primary neural cells differentiated into neural cells or integrated into been presumed to be aging-related declines in striatal dopamine (DA) networks formed by the primary brain neurons. In contrast, more neucontent, and several often cited studies suggest that the pattern of rons from all three brain regions survived longer in coculture with changes in the DA system in aging and PD bear minimal relationship HUCB. Further, BrdU incorporation was increased in cocultured neuto one another. We have begun to revisit this issue in nonhuman prirons from SVZ and hippocampus compared to monocultured cells.
mates and incorporating what is known about regional differences in HUCB-treated neurons also expressed neural antigens and had more vulnerability to degeneration among ventral midbrain DA neurons in extensive neurite outgrowth even in cells harvested from the aging response to toxins and PD. Our hypothesis is that to the extent aging brain. The presence of synaptophysin immunoreactivity in the neurites participates in the etiology of PD, markers of cell structure and funcsuggests that these cells were forming functional synaptic connections.
tion of relevance to PD will increase with advancing age and accumu-Ongoing studies focus on identifying the underlying mechanism(s) of late specifically in DA neurons vulnerable to degeneration [substantia HUCB cells' supportive effects on the development of neurons. nigra ventral tier (SNvt)] compared to DA neurons resistant to degen-Supported by NIH. S.G.D., A.E.W., and P.C.B. are selective vulnerability of SNvt DA neurons to degeneration in PD. In addition, we have shown that aged monkeys exposed to an MPTP insult are incapable of engaging the biochemical compensatory re-Previously, we have reported the generation of proliferating endogenous neural progenitor cells (NPCs) at a remote distance following sponse of increased DA turnover that is preserved in young adult and middle-aged animals. Furthermore, in response to the same insult, acute spinal cord injury in rats. In this study, we demonstrate that embryonic dorsal root ganglia/spinal cord NPCs transplanted at the aged subjects do not elevate striatal trophic activity while young subjects do. This trophic compensatory response is elevated at baseline in injured thoracic cord migrate to the brain and migrate throughout the aged animals, suggesting that as a consequence of events occurring well as in humans with PD and AD. The cytokines tumor necrosis factor-α (TNF-α) and vascular endothelial growth factor (VEGF) also with advancing age trophic compensation is saturated. Taken together, our findings indicate that specific markers of impaired cellular func-have angiogenic activity, which initiate the formation of new vessels that do not form a competent blood-brain barrier (BBB) until mature. tion do accumulate during aging and localize to DA neurons of the SNvt vulnerable to degeneration in PD. In addition, the aged nigrostri-
We have previously shown colocalization of the angiogenic marker integrin αvβ3 with FITC-labeled albumin leakage in the substantia atal system becomes incapable of biochemical and trophic compensation to forestall degenerative events when faced with toxic insult. It is nigra (SN) and striatum in an animal model of PD (Eur. J. Neurosci. 5:1158; 2005) . This study sought to determine whether leaky, angio-our contention that aging-related changes may be significant contributors to incipient parkinsonism and the study of these changes may genic vessels also occurred in human PD and AD. Twenty postmortem human brain samples were obtained from the Religious Order Study, clarify the natural history of PD.
a were also positive correlations between nigral neuron loss and number Gainesville, FL, USA of tangles in the SN with intensity of integrin αvβ3 staining, suggest- †Department of Molecular Genetics, University of Florida, ing that degree of cell death and inflammation coincides with angio-Gainesville, FL, USA genesis. Because angiogenesis is an intermittent process, we also eval- ‡Department of Pharmacology, Dalhousie University, uated the total number of mature vessels. A greater number of vessels Halifax, CA, USA were observed in the SN of AD postmortem tissue, specifically in the dorsal tier. Interestingly, greater number of vessels was observed in The recent advances in RNA interference (RNAi) technology have the locus coeruleus of AD tissue even though integrin αvβ3 staining led to the rapid development of nucleic acid-based gene therapies for was only present in PD tissue. Though αvβ3 staining was not observed the treatment of disease. We designed two hammerhead ribozymes in the putamen, there were a greater number of vessels in the PD tissue (HD6 and HD7) and a short-hairpin RNA (siHUNT-2) directed against compared to control. In addition to the vascular changes in the SN, a region between nucleotides 342 and 363 of the human huntingtin IgG was detected in the SN parenchyma of PD and AD tissue and not mRNA in order to suppress the expression of striatal m-Htt in the R6/ in control tissue. Positive αvβ3 staining in PD and AD tissue indicated 1 transgenic model of HD. The binding sites for the HD6 and HD7 some vessels were undergoing angiogenesis at the time of death. In ribozymes overlapped the siHUNT-2 targeted site. Long-term rAAV5addition, regardless of integrin staining, some areas had a greater nummediated expression of siHUNT-2 in R6/1 mice led to a significant ber of vessels compared to control, suggesting there was a history of decrease in the levels of m-Htt mRNA and protein as well as a remarkongoing angiogenesis. The presence of IgG within the parenchyma able reduction in the size and numbers of neuronal intranuclear incluindicates that vascular leak and/or extravasation of inflammatory cells sions. However, we were unable to detect in vivo knock-down of has also occurred. Because proinflammatory cytokines possess both m-Htt after the expression of either HD6 or HD7 hammerhead riboinflammatory and angiogenic activities, the elevated levels of TNF-α zymes. Contrary to the expected result, rAAV5-mediated expression and VEGF observed in PD and AD could activate the endothelium of siHUNT-2 resulted in a dramatic reduction in the levels of preproand disrupt the BBB, enhancing the extravasation of inflammatory enkephalin (ppEnk), dopamine-and cAMP-regulated phosphoprotein cells and allowing for the infiltration of neurotoxins resulting in disof 32-kDa (DARPP-32), and the dompamine type-2 receptor (D2R) ease progression. mRNAs in both transgenic and wild-type mice. This reduction was not Support contributed by NIAID AI05161, NINDS NS045316, K08 due to an overall suppression in neuronal transcriptional activity be-AG00084. cause expression of the nerve growth factor-inducible A (NGFi-A) transcript was induced to 20% above wild-type levels in both R6/1 and wild-type mice. These results were also observed in HD6-or
The Novel Neuroimmunophillin, GPI 1485, Attenuates HD7-treated animals. Long-term expression (ϳ12 months) of si-Age-Related Cognitive Deficits in Rats HUNT-2 in the striatum of wild-type mice led to a loss in DARPP-32 immunoreactivity as well as an enlargement of the lateral ventricles. Fischer 344 rats were assessed for their ability to locate a hidden plat-Proinflammatory cytokines are known to be elevated in animal form in a standard Morris water maze (MWM) task. Rats were initially trained for 3 days in the cued platform version of the MWM task, in models of Parkinson's disease (PD) and Alzheimer's disease (AD) as 320 ABSTRACTS which a flag was attached to the platform that was located in the center were present and mainly found in layers II and III. These neurons showed about 50% colocalization with calretinin, which may indicate of the maze. The day following completion of the cued task, the flag was removed and the submerged platform was moved to the middle that they are GABAergic interneurons. In addition, FA1-ir neurons were identified in the CA3 region of the hippocampus, in the olfactory of the northwest quadrant of the maze for the hidden portion of MWM testing. Hidden testing was carried out for 5 days, and the distance bulb and in calbindin-positive neurons in the cerebellum. In sum, FA1 expression was detected in different phenotypes of neurons in specific traveled to find the hidden platform on the last 2 days of testing was used to separate the aged rats into three groups. Relative to a group of regions of the adult rat brain. young rats, those aged rats whose distance swum was 4 or more standard deviations above that of the young rats were placed in the im-Current Challenges in Parkinson's Disease Research: paired group, those whose distance swum was between 3 and 4 stan-
The Role of Nonhuman Primates dard deviations were placed in the intermediate group, and those rats whose distance swum was within 3 standard deviations of the young E. M. Emborg rats were placed in the unimpaired group. Within these groups rats were randomly placed into either a treatment group that received 10 Preclinical Parkinson's Research Program, Wisconsin National mg/kg GPI 1485 or a vehicle group that received an equivalent volume Primate Research Center and Department of Anatomy, University of saline, both treatments delivered via oral gavage, beginning 3 days of Wisconsin, Madison, WI, USA after the hidden portion of MWM and continuing daily throughout the remainder of the study. Twenty-two days after the commencement of
The two basic goals of modeling Parkinson's disease (PD) in nongavage, a 5-day retention task was performed, with the hidden plathuman primates (NHP) are to assess possible causes of PD and to form located in the northwest quadrant. Following the retention test, a evaluate therapies. Today the role of NHP research for PD is vital probe trial, in which the platform was removed, was conducted and in both fronts. Currently there are efficient models of PD based on the distance swum in all four quadrants was recorded. Following the neurotoxins (e.g., MPTP) that are still providing a framework to unprobe test, rats received 3 days of reversal testing in which the platderstand PD physiopathology and assess therapies. Yet there is a need form was placed in the middle of the southeast quadrant. Results indito develop new monkey models of PD based on identified risk factors, cated that vehicle-treated/impaired rats were swimming significantly such as pesticides, that may induce not only nigral cell death but degreater distance than rats from all other groups during retention testvelop Lewy body-like structures, ideally in a progressive, replicable, ing, whereas those rats in the immunophillin-treated/impaired group and predictable fashion. These "toxic" models may help bring awarewere only swimming farther than young rats. Both groups of aged ness of avoidable environmental risks, allow evaluation of the patholimpaired rats, as well as vehicle-treated/intermediate rats traveled sigogy in the primate brain, and provide a new model to assess therapies. nificantly greater distance than young rats on days 2 and 3 of MWM In the past decade six different genes have been identified as causing reversal testing, whereas immunophillin-treated/intermediate rats and familial PD. Specifically, mutations in α-synuclein, parkin, UCHL1, both groups of unimpaired rats were not significantly different from DJ1, PINK1, and LRRK2 have been linked to PD, with a mendelian young rats. These findings suggest that GPI 1485 has significant popattern of inheritance. Direct gene transfer using AAV or lentiviral tential to counteract aged-related memory deficits and that further revectors can be used to assess in adult nonhuman primates the effect search to elucidate the possible mechanisms, including potential alterof overexpression of different mutated proteins that have been linked ations in calcineurin and GAP-43 levels, which may be critical to familial forms of PD. Fully characterized models of the different components underlying these protective effects, is warranted. mutations, targeting different areas of the brain can allow testing of novel therapies aiming to specific pathways of degeneration. The invasive nature of current gene therapy strategies by definition requires NHP testing. Current gene therapy trials lack an intrinsic ef-Fetal antigen 1/delta-like (FA1), encoded by the gene DLK1, is a fective method of stopping gene expression in case of complications. transmembrane protein belonging to the epidermal growth factor su-NHP research will be essential to judge efficacy and safety of new perfamily. FA1 has been found in cells derived from the fetal ventral genes, vectors, and conditional expression systems. Gene silencing mesencephalon and was proposed to be potential alternative marker strategies present the possibility of cross-silencing normal genes or protein for immature dopaminergic neurons. Notably, we have prenonaffected areas, and appropriate NHP studies could assess these viously shown that FA1 is expressed in a majority of neurons in the risks. adult rat ventral mesencephalon. FA1 expression was furthermore de-Acknowledgements: Kinetics Foundation. tected in the locus coeruleus, in the Edinger-Westphal's nucleus and in certain parts of the raphe nuclei. Nevertheless, at present it is not
Assessment of intracerebral interventions with clinical potential as
The High-Density Fraction of Bone Marrow Is Enriched known which function and role FA1 plays in the adult brain. The presfor Mesenchymal Stem Cell CFU-F ent study aimed at investigating the expression pattern of FA1-ir cells in the adult brain in more detail. We observed that FA1-ir cells were focally distributed in various brain regions. Numerous FA1-ir cells A. Ferrari, C. Pascual, and N. El-Badri were present in the basal forebrain, particularly in the lateral septal area, while only few cells were found in the medial septal nucleus Department of Neurosurgery, Center of Excellence for Aging and no FA1-ir cells were detected in the septohippocampal nucleus. and Brain Repair, University of South Florida, Tampa, FL, USA Interestingly, colocalization analyses revealed no double labeling with choline acetyl transferase and p75NGFR, indicating that these cells are Mesenchymal stem cells (MSCs) refer to a population of progenitors that provide a supportive microenvironment for maturation and likely not cholinergic neurons. In cerebral cortex few FA1-ir cells differentiation of the bone marrow (BM) hematopoietic stem cells, and RST was consistently more efficient than the CST at anterogradely transporting GDNF from the brain to the spinal cord. may provide stem cells for somatic tissue regeneration. MSCs are multipotent cells that can be induced to differentiate into adipocytes, Supported by grants from Families of Spinal Muscular Atrophy and the NIH. reticular cells, osteocytes, connective tissue cells, and neural cells. Furthermore, MSCs downregulate the immune response, thus requiring less immune suppression in transplant regimens. These criteria qualify MSCs as prime candidates for purposes of cell therapy of neu-Memory Loss and Lipid Homeostasis: A Gut Feeling rological disorders. To optimize the use of MSCs for therapeutic purposes, a protocol to culture and expand MSCs in large numbers is L. Freeman,* C. Stevens, † V. Haley-Zitlin, † K. Sambamurti,* needed. The purpose of this study is to determine a method of harvest-V. Zaman,* A. Moore,* C. Umphlet,* J. Lockrow,* I. Singh,* ing a large number of MSCs from the bone marrow using density gradiand A.-C. Granholm* ent separation. Bone marrow was harvested from the long bones of male B57/Bl6 mice. Whole BM was fractionated using Ficoll density *Department of Neuroscience and Pediatrics, and the Center medium. Equal number of cells from the high-density fraction, lowon Aging, Medical University of South Carolina, density fraction, and whole bone marrow were plated on tissue culture Charleston, SC, USA plates. Cells were plated at low density to form CFU-F (colony form- †Department of Food Science and Human Nutrition, Clemson ing-unit fibroblasts). The number of CFU-Fs obtained per 10 6 plated cells was used to calculate the CFU-F plating efficiency. Cells were University, Clemson, SC, USA cultured for 9 and 16 days before staining. In both the 9-and 16-day cultures, the high-density fraction produced more colonies than the Lipids play an essential role in the brain as insulators, messengers, low-density fraction, and was comparable to whole bone marrow culand structural supports. Recent evidence has shown their association ture. We conclude that the high-density fraction of the BM, as well as with the development of Alzheimer's disease, a progressive neurodewhole BM, are more enriched for CFU-F than the low-density fraction.
generative disorder that greatly affects the elderly population. The molecular mechanisms that define this disease are currently not well understood. However, it is known that the formation of extracellular amyloid plaques and intracellular neurofibrillary tangles along with The Rubrospinal Tract Is More Efficient Than Corticospinal severe neuronal loss and demyelination of the axons occurs. Interest-Tract at Anterogradely Delivering rAAV5-Derived GDNF ingly, it has been found that brain-specific synthesis of cholesterol can to the Spinal Cord influence the pathogenesis of the disease, but it is also important to investigate how dietary fats can affect this system. Therefore, a rat K. D. Foust, T. R. Flotte, P. J. Reier, and R. J. Mandel model system has been used in order to explore the effects of a high cholesterol diet, high saturated fat diet, high hydrogenated fat diet, and control diet on the development of the disease and, more simply, mem-Departments of Neuroscience and Pediatrics, McKnight Brain ory loss. The diets will be evaluated for their influence on behavior, Institute, Powell Gene Therapy Center, Movement Disorders Center, brain biochemistry, and morphology in order to better understand the University of Florida College of Medicine, Gainesville, FL, USA underlying molecular mechanisms that work against lipid homeostasis to cause Alzheimer's disease. Previous studies from our laboratory Neurodegenerative diseases such as spinal muscular atrophy have shown a significant reduction in dendritic integrity as well as (SMA) and amyotrophic lateral sclerosis (ALS) are characterized by a learning deficits in middle-aged rats on a high saturated fat/high choloss of the lower motor neurons in the spinal cord. Because ALS is a lesterol diet. The current study aims to examine if hydrogenated lipids progressive neurodegenerative disease and vector-mediated CNS (i.e., 'trans fats") are more detrimental on these parameters due to the transduction has been shown to mediate long-term protein expression, ongoing debate about their damaging effects. We found that levels of gene therapy may be a viable treatment option. One promising aptriglycerides, high-density lipoprotein (HDL), very low-density lipoproach is the use of multiple intramuscular injections of recombinant protein (VLDL), and total cholesterol are all significantly elevated for adeno-associated virus to deliver secreted trophic factors to spinal mothe trans fat diet group compared to other groups, and these rats comtor neurons (Kaspar et al.; 2003) . However, intramuscular delivery mitted more memory errors on a working memory task. Morphological could involve hundreds of injections to completely treat an ALS paand biochemical studies are under way. The current data suggest that tient. Alternatively, the relationship between the upper and lower motrans fats may be more damaging to memory correlates than other tor neurons can potentially be utilized to deliver trophic factors to high-fat diets. large areas of the spinal cord via a single intracerebral injection. In Supported by AG04418 and AG12122. this study, we compared two descending tracts, the corticospinal (CST) and rubrospinal (RST), for their efficiency of delivering rAAV5 derived GFP or GDNF to the spinal cord. Unilateral injection of Extrinsic or Intrinsic Manipulations Alone Are Insufficient rAAV5 GFP into the red nucleus or motor cortex of normal rats proto Promote GABAergic Differentiation in Cultured Rat duced GFP-positive fibers in the appropriate descending tracts as well Embryonic Neural Precursor Cells as cervical, thoracic, and lumbar levels of the spinal cord. Descending GFP-positive fibers were noted in the dorsal white mater contralateral O. Furmanski,* † S. Gajavelli,* J. Huang,* and J. Sagen* † to the injected side for the CST. GPF-positive RST fibers were seen in the dorsolateral funiculus contralateral to the injected side. For both *Miami Project to Cure Paralysis, University of Miami Miller labeled tracts, axonal projections into the gray matter were consistently School of Medicine, Miami, FL, USA seen at all levels of spinal cord examined using GFP immunohisto- †Neuroscience Program, University of Miami Miller School chemistry. The gray matter infiltration was greater in the CST cohort of Medicine, Miami, FL, USA compared to the RST cohort when injected with rAAV5 GFP. However, when injected with rAAV5 GDNF the inverse was true. GDNF IHC in the spinal cord was difficult to detect in the CST group. The Several CNS disorders, including epilepsy, stroke, and neuropathic pain, display a loss of inhibitory neurotransmission in and around the RST group maintained a similar pattern to its GFP staining, showing GDNF-positive fibers entering the spinal gray matter. GDNF IHC in affected region. This disinhibition can be ameliorated with drugs that promote γ-aminobutyric acid (GABA) signaling. However, systemic the brains confirmed correct injections across both cohorts. The CST group also had abundant GDNF staining in areas of the brain known treatment of a focal disorder may result in considerable side effects. Transplantation of GABAergic neural precursor cells (NPCs) is an al-to receive projections from the cortex. The RST group's GDNF staining was confined to the midbrain. GDNF ELISA of cervical, thoracic, ternate strategy for promoting local restoration of inhibitory signaling in the damaged or diseased nervous system. Preliminary studies in our and lumbar levels of the spinal cord confirmed the GDNF IHC results.
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ABSTRACTS lab have shown primary neurospheres (NSs) generated from E14 rat DNA. Unlike with bicistronic vectors where the expression from reporter wanes following integration, expression from this construct was telencephalic NPCs contain numerous GABAergic neurons and can attenuate spinal cord injury-induced neuropathic pain in rats. Our labo-affected by integration and sustained over long periods. In order to ensure synthesis and secretion of SHG was unimpeded by addition of ratory is exploring methods for further enriching long-term NPC cultures for a GABAergic phenotype for transplantation, while inhibiting mRFP, the cDNAs were separated by a dibasic residue (KR); additionally, an endoplasmic retention signal, KDEL, was used to facilitate gliogenesis. Promotion of neurogenesis may be possible using either environmental (extrinsic) or molecular (intrinsic) manipulations. De-retention of the mRFP in the endoplasmic reticulum (ER). We found that this is a robust strategy and works in cell types such as neural creasing concentration of FGF-2 in the culture medium was used to manipulate the extrinsic growth environment because recent reports stem cells, bone marrow cells, chromaffin cells, and related cancer cell line PC12. Cells contained numerous red fluorescent vesicles of demonstrate that elevated FGF-2 levels favor gliogenesis at the expense of neurogenesis. In addition, it has been suggested that transient mRFPKDEL. Consistent with the synthesis, processing, and secretion of the SHG peptide, immunostaining of these cells for SHG showed FGF-2 withdrawal can promote GABAergic neuronal differentiation through an unknown mechanism. To manipulate NPCs intrinsically, that some of the red fluorescent vesicles also co-stained for SHG. Cells could be sorted using fluorescence-activated cell sorter based on their cells were infected with a lentiviral vector driving constitutive expression of MASH1, a proneuronal basic helix-loop-helix (bHLH) tran-fluorescence. Biochemical, immunostaining, and electron microscopy data suggest that the polypeptide is synthesized and efficiently pro-scription factor. Expression of MASH1 is an early step in the gene expression cascade of developing telencephalic GABAergic neurons.
cessed into peptide SHG and cellular label mRFP, and that the mRFP is retained within the cells. Long-term in vitro expression studies over Naive and eGFP-transduced NPCs were used for comparison. Results showed that transient FGF-2 withdrawal from NS cultures produced a year showed sustained peptide release of peptide. Cells modified by this construct may serve as "cellular minipumps" of SHG and possess subtle phenotypic differences between GABAergic neurons in treated and control cultures without any substantial changes in proliferation the therapeutic potential for treatment of neuropathic pain. or percent GABAergic differentiation. Long-term FGF-2 withdrawal also did not promote NPC commitment to a GABAergic neuronal fate in vitro, as demonstrated by absence of BrdU-GABA double-immuno-Antisense RNA Sequences Modulating the Ataxin-1 Message: reactive neurons. Western blotting revealed that endogenous MASH1
Molecular Model of Gene Therapy for Spinocerebellar expression in both naive and eGFP-transduced NPCs decreases
Ataxia Type 1, a Dominant-Acting Unstable Trinucleotide through successive passages and is virtually absent by passage 3. In
Repeat Disease contrast, MASH1-transduced NPCs displayed increased MASH1 expression that is sustained at least through passage 3 thus far. In naive Y. Gao,* † T. Zu,* ‡ W. C. Low, § H. T. Orr,* † ‡ and eGFP-transduced NPCs, GFAP expression increases over succesand R. S. McIvor* † ‡ sive passages, and is prominently expressed by passage 3. In contrast, GFAP expression is greatly diminished in MASH1-transduced NPCs *Institute of Human Genetics, University of Minnesota, at this stage, suggesting reduced differentiation to an astroglial pheno-Minneapolis MN, USA type. However, expression of CNPase, an oligodendroglial marker, †Department of Genetics, Cell Biology and Development, and HES1, a bHLH repressor and inhibitor of differentiation, remained equal in all conditions. These data suggest that forced expression of University of Minnesota, Minneapolis MN, USA MASH1 restricts NPCs from an astroglial fate but may be insufficient ‡Department of Laboratory Medicine and Pathology, University to promote GABAergic neurogenesis in the presence of ongoing HES1 of Minnesota, Minneapolis MN, USA expression. Ongoing experiments will examine combinations of extrin- §Department of Neurosurgery, University of Minnesota, sic and intrinsic manipulations to more closely mimic the complex Minneapolis MN, USA interplay of genes and environment during embryonic neural development in vivo.
Spinocerebellar ataxia type 1 (SCA1) is a dominant inherited dis-Supported by NS51667. ease caused by expanded trinucleotide repeats resulting in an increased polyglutamine tract in the gene product. As a potential therapeutic approach for SCA1, we tested antisense RNAs targeting two regions of the ataxin-1 message. Single-stranded regions around the transla-A Novel Strategy to Enhance Sustained Analgesic Peptide tional initiation site and the intron 8 splice donor site of the ataxin-1 Secretion and Cell Labeling for Transplantation message were identified by computer-assisted RNA secondary structure prediction. Plasmids were generated to contain a 254-bp antisense S. Gajavelli, D. A. Castellanos, J. Huang, A. Hama, M. E. Guimera, sequence spanning the translation initiation site (pLasBDini) or a 317and J. Sagen bp sequence spanning the intron 8 splice donor site (pLasBDei) of the ataxin-1 message. These plasmids were transfected into Chinese ham-Miami Project, University of Miami, Miami, FL, USA ster ovary cells engineered to express either expanded or unexpanded ataxin-1 message and protein. Reduced levels of mutant ataxin-1 message (82 CAG repeats), wild-type ataxin-1 message (30 CAG repeats), N-Methyl-D-aspartate glutamate receptor (NMDAR) and µ-opioid and ataxin-1 protein were observed by Northern and Western analysis receptor antagonists can be used for the alleviation of pain; however, in pLasBDini transfected clones. pLasBDei transfected 293 cells exassociated side effects of exogenous administration of these substances hibited a shift in ataxin-1 message to a size several kilobases longer limit their clinical potential. Chromaffin cells release a combination of than that of the natural message. Reverse transcriptase/polymerase pain-reducing neuroactive compounds including opiates and histochain reaction assays demonstrated the retention of message spanning granin, an NMDA antagonist. Previous studies in our laboratory have the intron 8 splice acceptor and the inability to amplify sequences demonstrated that the allogeneic transplantation of chromaffin cells between exons 8 and 9, implying that normal splicing of intron 8 had in the subarachnoid space alleviates pain in various models. Serinebeen interrupted. We conclude that antisense RNAs were effective in histogranin (SH), a stable analog of histogranin, attenuates neuropathic reducing or modifying ataxin-1 messages in transfected cells, and may and inflammatory pain with no attendant motor abnormalities. SHG is thus be an effective genetic strategy for therapy of SCA1 and similar a safe and useful adjunct in the management of chronic pain. We dominant, neurological disorders. sought to genetically enhance the pain-reducing neuroactive peptide content of the chromaffin cells. Using recombinant DNA approach we combined a synthetic SHG gene with the nerve growth factor-β (NGFβ) amino-terminal signal peptide. The construct enabled constitutive secretion of SHG. To prospectively isolate cells secreting recombinant SHG, red fluorescent protein mRFP was added in frame with SHG Tampa, FL, USA to, or substitute for, cells in developing clinically useful protocols for **Saneron CCEL Therapeutics, Inc., Tampa, FL, USA cell-based ALS therapies. The aim of this study was to determine the efficacy of hUCBP on the functional activity of lymphocytes from the peripheral blood of ALS patients. Peripheral blood (PB) was obtained Sanfilippo syndrome type B is an inherited disorder caused by deficiency of the alpha-N-acetylglucosaminidase (Naglu) enzyme in the from six ALS patients and three healthy volunteers. Complete blood counts (CBCs), including white blood cell differential (WBCD), IgG degradative pathway of heparan sulfate (HS). Our previous studies showed that a single administration of Saneron's proprietary fraction and IgM levels, were performed and concentrations of Th1/Th2 cytokines determined. Four ALS patients (group 1) had low normal WBC (U-CORD-CELL TM ) of mononuclear human umbilical cord blood (hUCB) cells into the cerebral ventricle of presymptomatic Naglu mice counts (5.1 ± 0.7 10 4 /µl), and two ALS patients (group 2) had higher counts (8.6 ± 2.2 10 4 /µl) than normal volunteers (7.2 ± 2.4 10 4 /µl). or intravenous cell delivery at different stages (early symptomatic or late stage) of disease had a beneficial effect, probably due to enzyme There were elevated lymphocytes in the WBCD of group 1 (32.3 ± 5.2%) compared to both group 2 (18.8 ± 0.9%) or normal volunteers delivery into the enzyme-deficient mutant mice. Transplanted mutant mice showed cognitive improvement and decreased disease-related hy-(26.3 ± 6.9%). However, neutrophils were elevated only in group 2 (70.4 ± 3.3%). Levels of IgG were high in group 1 and low in group peractivity even when cells were administered in the late stages of the disease. After intracerebroventricular or intravenous administrations of 2 while the IgM profile was opposite. These results for group 2 are indicative of early stage infections. MNC from PB (MNC PB) were hUCB cells, the cells were found widely distributed within and outside the CNS. HS accumulation was significantly reduced in the liver and also isolated and plated (25 × 10 3 ) in triplicate in 96-well plates with either RPMI-1640/10% FBS (medium 1) or RPMI-1640/10% hUCBP spleen of Naglu-treated mice with a more drastic reduction in the liver of females. However, most observed behavioral benefits in Naglu mice ABO Rh matched (medium 2). After 24-h incubation, the cultures were stimulated with phytohemagglutinin (PHA, 10 mg/ml) and the were limited to the first months after cell transplantation, possibly due to declining production of the missing enzyme over time. The aim of cell colonies counted at 24, 48, and 72 h. The index of stimulation (IS) was determined as the number of induced colonies/number spon-our preclinical translational study is to determine the effect of multiple intravenous transplantations of hUCB cells into Naglu mice. Cells or taneous colonies in control wells. In a second study, MNC PB were incubated in medium 1 for 5 days, after which the cells were incubated media were injected in 3-month-old mutant mice into the tail vein. In multiple cell administrations, 3 × 10 6 cells were delivered monthly for in medium 2 for 24 h. Caspase 3 and 7 activities were determined in these cells using a MR-(DEVD)2 kit. There were three different re-6 months. Dosages for single injections were 3 × 10 6 cells (control for each multiple injections) or 18 × 10 6 cells (control for entire series of sponse profiles of MNC PB to PHA stimulation when the cells were incubated with medium 1. MNC PB from a normal control had an IS multiple injections). At 1 week pretransplant and at monthly intervals for 6 months posttransplant, the animals participated in behavioral index of 32 at 24 h to 50 at 72 h of incubation. IS of MNC PB from some of the ALS patients was similar, but we also observed patterns tests of spontaneous locomotor activity (open field) and cognitive function (active avoidance). As we showed previously, results of the of increased stimulation with a decreasing trend over time (abnormal extensive proliferation) and noninducible proliferation. When medium present study demonstrated that the Naglu mice had early hypoactivity (3 months of age) with impaired learning (mostly in males) followed 2 was used, proliferation of cells exhibiting the abnormal extensive 324 ABSTRACTS by hyperactivity and memory impairment with aging (8-9 months of Intraputamenal Delivery of Exogenous Neurturin Improves Motor Function in MPTP-Lesioned Rhesus Monkeys age) of both sexes. Multiple administrations of hUCB cells into these early symptomatic mutant mice showed significant improvement in locomotor activity of both sexes with repeated cell transplants. Cogni-R. Grondin,* † Z. Zhang,* † Y. Ai,* † F. Ding,* G. A. Gerhardt,* tive function (learning) improved in multiple treated mutant males and D. M. Gash* † mainly at the third and fourth months after cell grafting, whereas memory tended to be enhanced at fifth and sixth posttransplant months.
*Department of Anatomy and Neurobiology, University of Kentucky, During acquisition, multiple treated mutant females showed learning College of Medicine, Lexington, KY, USA improvement at the fifth and sixth months after transplantation, al- †Morris K. Udall Parkinson's Disease Research Center though their improved memory was observed earlier, in the third of Excellence, University of Kentucky, College of Medicine, month posttransplant. Immunohistochemical analysis of administered Lexington, KY, USA hUCB cells in the peripheral blood showed the presence of grafted cells in the blood circulation of mutant mice increasing after each cell ‡Center for Sensor Technology, University of Kentucky, College injection. Our results demonstrated that multiple intravenous adminisof Medicine, Lexington, KY, USA trations of hUCB cells into Naglu mice at early symptomatic stage of disease has a beneficial effect compared to a single cell injection, Parkinson's disease (PD) is characterized by bradykinesia, tremor, probably due to continuous enzyme delivery into the enzyme-deficient and rigidity due to the loss of functional dopaminergic neurons in the mutant mice. nigrostriatal pathway. The well-documented trophic actions of GDNF Supported by the Children's Medical Research Foundation. S.G.D.
on midbrain dopamine neurons provide a potential but controversial and A.E.W. are consultants to and P.R.S. is a cofounder of Saneron therapeutic approach for the treatment of PD. As an alternative to CCEL Therapeutics, Inc.
GDNF, other members of the GDNF family ligands may also have therapeutic potential. Neurturin is structurally related to GDNF and was shown to exert similar trophic effects on dopaminergic function in rodents. Here, we studied the restorative effects of exogenous neurt-Who Gave the Prize and Who Received It? A Playful Account urin on dopaminergic function in 10 MPTP-lesioned rhesus monkeys of Alfred Nobel and Some of the Neuroscientists Receiving expressing long-term parkinsonian symptoms. Using MRI-guided stethe Nobel Prize reotactic procedures, a multiport catheter was surgically positioned into the putamen and connected to a computer-controlled pump im-A.-C. Granholm planted in the abdominal region. The animals were blindly assigned to receive coded solutions containing either vehicle (n = 5) or neurturin Department of Neurosciences and the Center on Aging, Medical (n = 5, 30 µg/day) co-infused with heparin using convection-enhanced University of South Carolina, Charleston, SC, USA delivery for 3 months. Changes in motor function were assessed using a nonhuman primate parkinsonian rating scale. Also, the videotaped In 1906, Santiago Ramon y Cajal won his Nobel Prize for showing images were digitized and analyzed using video-tracking software. A that neurons were independent cells, disproving the prevailing hypothsignificant 20% improvement in PD scores, along with a 28% increase esis that they formed a physically continuous net. He shared it with in locomotor activity, was found in the neurturin-treated group com-Italian anatomist Camillo Golgi, who favored the nerve net idea but pared to pretreatment baseline levels, but not in the vehicle-treated whose staining techniques allowed Cajal to see individual cells. Interanimals. At the end of the study, the animals were anesthetized and estingly enough, growing up the "Father of Neurobiology" did not transcardially perfused with heparinized saline. The brains were prowant to be a scientist. He wanted to be an artist. Cajal regarded school cessed so that 40-µm-thick coronal sections could be cut on a frozen as a prison and preferred spending his time outdoors. During what he sliding microtome and immunostained for neurturin. Tissue distribuconsidered especially boring classes, he scribbled in the margins, cretion of neurturin in the brain, quantified using three-dimensional reating art work in history or social studies class. His favorite drawings construction software, was limited to only 58% of the total putamen were battles between warriors-which were later transferred into batvolume (461 ± 112 mm 3 ). In comparison, tissue distribution of GDNF tles of the cells. We can still find his drawings in text books of Neuroachieved in our prior studies was almost twice as high (854 ± 81 mm 3 ) science. When Santiago was 11 years old, he destroyed a neighbor's in the putamen using a similar delivery method. Suboptimal tissue gate with a homemade cannon and spent 3 days in jail. How could it distribution of neurturin may explain why the level of improvement in be that this difficult child later became the Father of Neuroscience, motor function achieved with neurturin was only half of that seen with receiving the greatest honor of all?
GDNF in our prior studies. Our results support that neurturin could be Since 1901, the Nobel Prize has been honoring men and women effective for the treatment of PD. However, more studies are necessary from all corners of the globe for outstanding achievements in physics, to determine strategies to enhance the distribution volume of neurturin chemistry, medicine, literature, and for work in peace. The foundations and to optimize its trophic effects in the diseased brain. for the prize were laid in 1895 when Alfred Nobel wrote his last will, Supported by NIH Grant NS039787. Medtronic Inc. (Minneapolis, leaving much of his wealth to the establishment of the Nobel Prize. In MN) provided the pump/catheter system and Dr. Robert Klein prothe summer of 1889, Alfred Nobel was working on the first version vided neurturin and vehicle solutions. of his will. Already then he decided to donate most of his enormous wealth. In a letter to his lifetime love and friend Sofie Hess, he wrote, "I am anticipating with great pleasure the large amount of cuss words Fate of Embryonic Ventral Spinal Cord Cells Transplanted and angry faces when my will shall be announced." November 27, Into the Distal Tibial Nerve Stump of Adult Rats 1895 he signed his last will in Stockholm, where it was opened 5 days after his death, December 10, 1896. And he was right; similar to the R. M. Grumbles, V. W. Almeida, S. Sesodia, P. M. Wood, relatives of James Brown recently, his relatives tried to sue the estate; and C. K. Thomas the Swedish king Oscar II thought it was unpatriotic that this would be an international prize, and the Arch Bishop of Stockholm wanted
The Miami Project to Cure Paralysis, University of Miami Miller a new hospital. Alfred Nobel died from a massive stroke, unable to communicate with anyone and all alone. This talk will be in honor of School of Medicine, Lois Pope LIFE Center, Miami, FL, USA Alfred Nobel and the Neuroscientists who have been honored to receive the Nobel Prize in Physiology or Medicine through the years.
Denervation of limb muscles is prevalent in neurodegenerative diseases and injuries that devastate spinal motoneuron pools. Without intervention, the muscles will continue to atrophy. Transplantation of embryonic ventral spinal cord cells into peripheral nerve near denervated muscles is one strategy to restore innervation when no source of peripheral axons is available. Axons from the transplanted cells form of hippocampus (p < 0.01, Ara-c vs. saline). The number of TUNELpositive cells in the CA1 and CA3 was significantly higher in Ara-c-functional neuromuscular junctions and the transplants can be stimulated with low currents to produce muscle contractions for several treated mice than saline controls (p < 0.01). These data suggest that ischemia-induced NSC proliferation in the SGZ supports pyramidal hours (Thomas et al.; J. Neurophysiol 84:591-595; 2000) . To improve the extent and consistency of muscle reinnervation from embryonic neuron survival in the hippocampus. This study was supported by Louisiana Gene Therapy Research cells, it is important to understand the fate of the transplant, a heterogenous population of cells that initially contains stem cells, precursor
Consortium and CADASIL foundation of America. neurons, and 5-7% motoneurons. The aim of the present study was to characterize the survival of embryonic day 14-15 (E14-15) ventral spinal cord cells transplanted into the distal tibial nerve stump of adult Efficacy of Striatal Precursor Cell Grafting Fischer rats. One week after sciatic nerve section, 1 million dissociated Into the Hippocampus for Suppressing the Progression E14-15 ventral spinal cord cells in 10 L Neurobasal medium were of Status Epilepticus Into Chronic Epilepsy transplanted into the distal nerve stump. The transplants were recovered 1, 3, 7, 14, 28, or 70 days posttransplantation. Coronal sections B. Hattiangady, M. S. Rao, K. S. Rai, and A. K. Shetty (25 µm thick) were stained with antibodies to neuronal, vascular, and glial antigens. Initially the transplant was clumped in one location with Department of Surgery (Neurosurgery), Duke University Medical vascular cells and Schwann cells located on the perimeter of the trans-Center, Durham, NC, USA plant. Blood vessels began to penetrate the transplant mass on day 7
Research and Surgery Services, Durham VAMC, Durham, NC, USA but there were fewer neurons at this site. Synaptophysin and synaptic vesicles appeared between 7 and 14 days. After 14 days, neurons began to spread along the nerve trunk. Islet-1, a LIM homeodomain pro-Hippocampal lesion inflicted by status epilepticus (SE) or head injury initially results in epileptogenic structural changes and then tein, was expressed by some neurons on day 3, but by many neurons at day 14 and 28. Expression of the neuron-specific class III B-tubulin progresses into chronic spontaneous recurrent motor seizures (SRMS). More than 2 million Americans suffer from epilepsy and 40% of them antigen began on day 7 while neurofilament positive neurons (145 kDa) were found on day 14. In contrast, choline acetyltransferase have temporal lobe epilepsy (TLE). The TLE is typified by the progressive expansion of SRMS stemming from the limbic system regions (CHAT)-positive neurons were only seen at 28 and 70 days. Preliminary analysis shows that neuron survival across transplants varied such as the hippocampus. A significant fraction of TLE patients have chronic seizures that are resistant to antiepileptic drugs. Therefore, al-from 2% to 12% of initial values. There were also occasional smaller cell clusters outside the perineurium. Correlations of these data with ternative therapies that are useful for suppressing the evolution of the initial precipitating injury (IPI) into chronic SRMS are needed. As the the numbers of regenerating axons and muscle fiber areas will be used to show whether the location of the transplanted neurons and their onset of SRMS after an IPI typically transpires after a latent period, there is a window of opportunity for applying useful intervention strat-access to vascularization modifies functional outcome.
Funded by USPHS grant NS-39098 and The Miami Project to egies shortly after the injury. Because chronic epilepsy development after the SE or injury is associated with depletion of inhibitory Cure Paralysis.
GABAergic interneurons in the hippocampus, grafting of GABAergic precursors into the hippocampus shortly after the SE may restrain the development of chronic epilepsy. In this study, we ascertained the Ara-c, a Proliferating Inhibitor, Blocks Neural Stem Cell long-term effects of grafts of striatal precursors (a rich source of
Proliferation and Causes Hippocampal Neuron Loss Following
GABAergic interneurons) placed into the hippocampus shortly after Cortical Brain Ischemia in Mice the SE for restraining chronic epilepsy development. We administered kainic acid (KA) to adult F344 rats via 3-4 graded intraperitoneal W. Guo,* † C. Piao,* † Y. Xue,* W. Duan,* and L. Zhao* † injections (3.0 mg/kg bw/h), which elicited Stages III-V motor seizures for >4 h (i.e., status epilepticus), and partial hippocampal neuro-*Department of Cellular Biology and Anatomy, Louisiana State degeneration. A group of KA-treated rats received grafts of 5-bromo-University Health Sciences Center, Shreveport, LA, USA deoxyuridine (BrdU)-labeled, FGF-2 and caspase inhibitor-treated, †Department of Neurology, Louisiana State University Health striatal precursor cells (from the lateral ganglionic eminence of embry-Sciences Center, Shreveport, LA, USA onic day 15 rats) bilaterally into the hippocampus at 4 days after the SE. A second group of KA-treated rats received sham grafting surgery. A third group of KA-treated rats was maintained as "epilepsy-only" Neural stem cells (NSC) in adult brain have the capability of selfrenewing (proliferation) to maintain NSC pool and multiple lineage controls. The frequency of SRMS per hour was quantified in all three groups at 11 and 12 months after the SE, following which the rats differentiation to give rise to neuronal and glial cells. Recently, convincing evidence shows that brain ischemia triggers NSC proliferation were perfused for histological analyses of graft cell survival, and potential graft cell differentiation into inhibitory interneurons positive and differentiation, which has been proposed to play a role in functional recovery. The aim of the present study is to determine whether for γ-aminobutyric acid (GABA), parvalbumin (PV), calbindin (CBN), calretinin (CR), and neuropeptide Y (NPY). Animals grafted with stri-blocking endogenous NSC proliferation by cytosine arabinoside (Arac) exaggerates brain ischemia-induced neuron loss. Ara-c (2% in sa-atal precursor cells (n = 5) exhibited minimal SRMS. The overall frequency of SRMS was equivalent to 18-22% of that observed in ani-line) (n = 10) and equal volume of saline (n = 10) was intracerebroventricularly delivered by an osmotic minipump 1 day before brain mals receiving sham grafting surgery (n = 5) or "epilepsy-only" controls (n = 5). Analyses of grafts revealed that the survival in each ischemia. Cortical brain ischemia was produced by permanent ligation of the right common carotid artery and middle cerebral artery in adult transplant was equivalent to 33% of injected cells. Phenotypic analyses demonstrated that majority of surviving cells (87%) were neurons that C57BL mice. Bromodeoxyuridine (BrdU, 50 mg/kg, IP) for labeling NSC proliferation was administered twice a day for 7 days. One day comprised interneurons positive for GABA (69%), PV (35%), CBN (30%), CR (36%), and NPY (8%). Thus, striatal precursor cell grafting after the final injection of BrdU, mice were sacrificed. Serial brain sections were used for determination of infarction size. BrdU-labeled into the hippocampus after an IPI can considerably restrain the progression of IPI into chronic epilepsy. The presence of a large number cells and apoptotic cells were determined with immunohistochemistry and TUNEL method, respectively. Ara-c completely abolished NSC of GABAergic interneurons in grafts suggests that diminished frequency of SRMS in rats receiving striatal precursor cell grafts after proliferation in the subventricular zone (SVZ) and significantly inhibited NSC proliferation in the subgranular zone (SGZ) bilaterally, the SE is due to strengthening of the inhibitory control in the host hippocampus. which was determined by the number of BrdU-positive cells in the two neurogenic zones. Infarction size did not differ between Ara-c-Supported by NINDS Grants RO1 NS054780 & NS043507 to A.K.S. treated mice and saline controls. However, significant cell loss was observed in both ipsilateral and contralateral CA1 and CA3 subregions 326 ABSTRACTS
Analgesic and Antiarthritic Spinal Cord Remodeling by Calorie
Spinal cord injury (SCI) causes an increase in chondroitin sulfate glycosaminoglycans (CS GAGs). CS GAG degradation, commonly
Restriction Is Paralleled by Deleterious Effects on Spinal Cord Injury in Mice
achieved using Chondroitinase ABC (Ch′ABC), reduces the inhibitory nature of the injured spinal cord in rats and, in some instances, enhances recovery. These promising results led us to investigate the ef-I. D. Hentall,* M. L. Rodriguez,* K. A. Baker, † fects of CS GAG disruption in a larger, complex mammalian species, and W. A. Hargraves † the cat. Extension of potential therapeutics in the rat to the cat represents an important translational step. In addition to the cat's remark-*The Miami Project to Cure Paralysis, University of Miami, able locomotor capacity, the cat, unlike the rat, is capable of cough. Miami, FL, USA Thus, we can assess two motor systems whose damage is associated †University of Illinois College of Medicine, Rockford, IL, USA with significant morbidity following SCI. The cat also presents signifi-Dietary calorie restriction reportedly improves outcome following cant scale-up barriers that must be overcome to successfully treat the brain reperfusion injury in rats, perhaps by upregulating various CNS human CNS and, finally, our data suggest that some features of CS neurotrophins and limiting mitochondrial leakage of reactive oxygen GAG composition in the cat are more similar to that of the human species. However, earlier postinjury feeding reduces morbidity and than the rat. First, the activity of nine lots of Ch′ABC was tested at mortality in human brain injury and preinjury malnutrition is known 37°C & 39°C to mimic rat and human as well as cat body temperatures to be detrimental, so that the effect of dietary restriction in spinal cord and human fever, respectively. Activity was assessed using immunoinjury (SCI) is unpredictable. Here we report on nociception and motor histochemistry, FACE, and HPLC. Significant effects of lot and time behavior in C57BL/6J mice with collagen-induced arthritis or SCI on on thermostability were seen. Because average enzymatic activity was three diets: 60% calorie restriction (CR), ad libitum (AL), alternating significantly decreased by 3 days at 37°C and 1 day at 39°C, we chose days of fasting and AL (ADF). Arthritis was induced by two subderto use a subcutaneous port that allowed repeated dosing to test the mal injections of collagen plus adjuvant into the tail; dieting began 14 effects of Ch′ABC. Cats were conditioned to perform a variety of loweeks earlier. SCI was commenced either before (28 days) or after (2 comotor tasks and baseline locomotor and cough data were collected or 14 days) moderate contusion SCI at the T9 level. Free-field locomoprior to SCI. Ch′ABC was delivered every other day for 1 month posttion was scored 0-9 on the Basso mouse scale (BMS). Reaction lalow thoracic spinal cord hemisection and behavioral data collected petency (paw licking) on a 52°C hot-plate, measured weekly, was signifiriodically for ϳ5 months. General recovery trends, as well as specific cantly higher after 6 weeks of CR (compared with AL), but with ADF features of locomotion, were evaluated across a variety of basic and it was only significantly higher after maximum fasting and in the first skilled locomotor tasks. Compared to control groups, the Ch′ABC-6 weeks. Arthritis (redness and swelling) scores were less in CR than treated group showed accelerated rates of recovery on several forms in ADF or AL groups. Arthritic hyperalgesia (elevated hot-plate latenof locomotion. Recovery of specific locomotor features including incies) was blocked by CR but not ADF. Diet crossover between CR tralimb movement patterns and velocity regulation were greater during and AL for 12 weeks reversed the dietary effects on pain and arthritis;
both basic and skilled locomotion in cats treated with Ch′ABC. Hindcrossback restored them. The analgesic and antiarthritic effects of CR limb placement during skilled locomotion also was significantly but not ADF prompted a focus on CRs influence on SCI. CR prior to greater in the group that received Ch′ABC. General cough characteris-SCI proved highly detrimental; at 14 days, for example, postinjury tics were assessed from 4 to 21 weeks post-SCI in a subset of cats survival was 40% versus 76% for nondieting, while mean BMS score used for locomotion. Cough was elicited by stimulation of the vocal was 1.6 ± 1.1 (SEM) versus 3.3 ± 0.7). CR started 2 days or 14 days folds and epiglottis. Bilateral rectus abdominis (RA) EMG amplitudes after SCI also caused significantly lower BMS scores than in AL and rise times were evaluated along with esophageal pressure and rise groups. Crossover from AL to CR at 8 weeks postinjury produced no times. Surprisingly, these parameters were similar to normal values significant change in BMS score, ruling out acute effects of diet on post-SCI, showing incredible resiliency. However, cats treated with test performance after SCI. Immunohistochemical staining of 72-week Ch′ABC generated greater esophageal pressures than controls. These lumbar spinal cords of arthritic mice showed, in dorsal laminae, fewer results suggest that Ch′ABC affected motor drive to muscles active substance P fibers, but denser kappa-opioid receptors, met-enkephalin during cough, other than the RA. Collectively, these findings suggest fibers, and cyclooxygenase-2. CR elevated dynorphin, substance P, that the therapeutic effects of Ch′ABC have application across species, and IGF binding protein-6; it reduced inducible nitric oxide synthase, can enhance performance across diverse motor systems, and that cyclooxygenase-2, and fluoride-resistant acid phosphatase. CR caused Ch′ABC-induced recovery is persistent. little change in cytochrome C or met-enkephalin; it raised glutamic Supported by R01 NS050699, Daniel Heumann Fund, Department acid decarboxylase in arthritic mice, but lowered it otherwise. Effects of Veterans Affairs & T32 HD043730. of ADF on recovery from SCI and immunostaining of damaged spinal cords under different diets remain to be analyzed. The pattern of sub-Second-by-Second Recordings of Glutamate in Rat Spinal Cord stances expressed in the spinal cord during arthritis and CR is com-Utilizing Ceramic-Based Microelectrode Arrays plex; some may oppose observed changes in pain level, others may contribute. Although the long-term analgesic effects of CR are not mirrored by beneficial effects on SCI, ADF remains potentially prom-P. Huettl,* ‡ J. Hinzman, ‡ F. Pomerleau,* ‡ J. Geddes, † ‡ ising, because insulin-like growth factor 1 (IGF-1) is reported to fall and G. A. Gerhardt* ‡ in CR but rise in ADF and to promote recovery from SCI. tions. An attractive treatment option is the delivery of multipotential horn. White matter has AMPA and KA ionotropic receptors but few cells; however, the choice of an appropriate cell type for transplantaor no NMDA receptors. These differences between white and gray tion is significant. Recent advances in stem cell research suggest that matter indicate that extracellular glutamate regulation may be different adult sources of stem cells including bone marrow retain the plasticity in these areas. In vivo studies in rat SC showed average glutamate necessary for regenerative medicine applications while avoiding many signal amplitudes from thoracic cord of 14.5 ± 0.3 µM (gray, n = 127 of the ethical, immunological, and accessibility concerns surrounding signals) and 14.2 ± 0.4 µM (white, n = 37 signals); average glutamate embryonic tissues or xenografts. While this makes them attractive clinuptake rates in gray and white matter thoracic cord were 1.8 ± 0.1 µM/ ically, studies comparing bone marrow-derived mesenchymal stem s and 2.4 ± 0.1 µM/s, respectively. These compare to average glutacells (MSCs) to the more commonly transplanted neural stem cells mate amplitude and uptake rates in striatum of rat brain of 13.3 ± 0.9 (NSCs) are limited. We developed a novel method to induce murine µM and 4.1 ± 0.09 µM/s, respectively. Repeated ejections of KCl (225 bone marrow-derived MSCs to form nestin-positive spheres similar nl, 70 mM) at 20-s intervals in gray matter shows an attenuation of to NSC neurospheres, thus permitting a side-by-side comparison of stimulus-evoked release over time (3.8 to 2.2 µM), which was not neurospheres from MSCs and NSCs and their response to ECM proobserved in rat striatum. Depth analysis of SC showed a range of reteins for use within a tissue-engineered scaffold. NSCs were isolated sponses varying in amplitude with similar stimuli. The variability in from the germinal eminence of E14.5 GFP+ mice, and MSCs were stimulus evoked responses observed illustrates the heterogeneity that isolated from the bone marrow of 8-10-week-old adult male GFP+ is present in the SC. Further work is ongoing to confirm these results.
mice. Using our novel MSC neurosphere induction method, sphere The ability to obtain real-time measures of glutamate release and updiameter can be controlled by a function of the culture parameters. take with in vivo electrochemical recordings will advance our knowl-Like NSCs, MSC sphere formation is dependent on basic fibroblast edge of glutamate responses in SC function pre-and postinjury.
growth factor (b-FGF The deleterious effect of oxygen free radicals and its role in brain T. Fuchigami, and M. Marsala aging is an important issue. The use of antioxidants to combat this damage is poorly understood. This study attempts to characterize the Department of Anesthesiology, Gene Therapy Program, University potential beneficial effects of the antioxidant properties of blueberries of California, San Diego, CA, USA (BB) on brain circuitry in old rats. Nineteen-month-old male Fischer 344 rats were given either standard diets or diets enriched with 2% BB extract for 2.5 months. In this initial study there were three subjects in
In previous studies we have reported long-term survival of spinal neural precursors (NPs) isolated from E14 GFP+ transgenic rat spinal each group. Layer II-III cortical neurons of frontal cortex in the 21.5month-old rats (seven neurons per subject) were evaluated for the ex-cord when grafted spinally into cervical or lumbar spinal cord in naive immunosuppressed Sprague-Dawley rats (Kakinohana et al., 2004) . In tent of their dendritic branching using Golgi methods, which impregnates the dendritic branches for microscopic quantification. Two and the same study we have also shown that in GFP+ rat there is only modest or no neuronal expression of green fluorescent protein (GFP). a half months on the BB-enriched diet resulted in a significant increase in dendritic branching in the proximal half of the basilar dendritic In contrast, there was robust GFP expression in grafted astrocytes and oligodendrocytes. The goal of the present study was to develop and arbor of the neurons (a 14% increase). This suggests that even in old subjects, BB dietary supplementation appears to have a beneficial neu-test a lentivirus-based neuron-specific expression vector (HIV1-Syn-dsRed) that would allow simultaneous identification of neuronal roplastic impact on neuronal morphology: it can mitigate normal agerelated dendritic atrophy and loss of brain circuits. Work is currently (dsRed) and nonneuronal (GFP) elements in neural grafts derived from GFP+ SD rats. Spinal cord precursors were isolated from lumbar E14 in progress to further evaluate changes in dendritic spines in these groups.
spinal cord of the transgenic "green rat" (CZ-004). Precursors were 328 ABSTRACTS expanded in vitro using EGF and FGF. Ten days after isolation, cells histology. Confocal microscopy results showed a large number of EGFP+ monocytes were able to cross the blood-brain barrier and mi-were infected with HIV1-Syn-dsRed lentivirus and neuronal differentiation induced with retinoic acid (1 µM) for 5 days. Cells were grafted grate to the injection site in 6-OHDA mice. EGFP+ cells were observed in a larger area of the striatum in 6-OHDA-treated mice com-spinally in halothane-anesthetized SD rats with developed ischemic paraplegia. To induce spinal ischemia in halothane (2%)-anesthetized pared with vehicle-treated mice. Additional studies are under way to further investigate the migration of such cells into the brains and effi-rats, descending aorta was occluded for 10 min and combined with systemic hypotension. After ischemia animals were allowed to survive cacy of these monocytes as a gene delivery vector. for 2-3 weeks before cell grafting. The final cell concentration used for grafting was 15-20,000 cells/injection (0.5 µl).
Cell injections
The Glial Environment During Normal Aging and in Response were targeted into central gray matter between L2 and L5 segments. A to MPTP: Relevance to Differential Susceptibility total of 20-30 injections were made bilaterally. After grafting, animals to Degeneration survived for 1-2 months and were then perfusion fixed with 4% paraformaldehyde. Transverse spinal cord sections were prepared, stained N. M. Kanaan,* J. H. Kordower,* and T. J. Collier † with a set of primary antibodies including (NeuN, MAP2, GFAP, RIP, GAD65, GLYT2, VGLUT2), and analyzed with confocal microscopy. In all animals the individual grafts were readily identified by the pres-*Department of Neurological Sciences, Rush University Medical ence of bright green fluorescence. Confocal analysis of the individual Center, Chicago, IL, USA sections revealed the presence of a numerous dsRed-positive neurons. †Department of Neurology, University of Cincinnati, Terminal dsRed-immunoreactive boutons were also identified. Double Cincinnati, OH, USA labeling with GFAP and RIP antibody revealed that virtually all GFP+ cells were nonneuronal while all dsRed cells were NeuN or MAP2
Parkinson's disease (PD) is an age-related neurodegenerative dispositive. On average 40-60% of dsRed+ boutons were GAD65 immuorder characterized by dopamine (DA) neuron degeneration preferennoreactive, 25-30% were VGLUT2 positive, and less then 4% were tially in the ventral tier substantia nigra (vtSN) with relative sparing GLYT2 positive. These data demonstrate that labeling of NPs isolated of DA neurons in the dorsal tier SN (dtSN) and ventral tegmental area from GFP+ embryonic spinal cord with HIV1-Syn-dsRed lentivirus (VTA). The factors contributing to the differential susceptibility of provides a tool to identify effectively both neuronal and nonneuronal DAergic subregions have not been determined. Previously, we have cells after grafting. In addition, an intense expression of dsRed protein shown that aging DA neurons in the midbrain undergo regional and in boutons of grafted neurons demonstrates that such a labeling techtemporal changes that follow a pattern similar to the degenerative nique in conjunction with EM analysis will permit i) a reliable identifichanges seen in PD. It is likely that changes within the glial environcation of synapse formation between grafted neurons and the neurons ment also contribute to the differential susceptibility seen in PD. Inof the host, and ii) identification of neurotransmitter phenotype of deed, inflammation and astrocytosis have long been believed to be grafted neurons.
major contributing factors in the pathogenesis of PD. Little work has been done to characterize regionally specific changes in the glial environment in normal aging and in response to MPTP. In the current study, we used young (8-10 years), middle-aged (14-17 years), and Monocyte Trafficking as a Gene Therapy Vector old-aged (22-31 years) rhesus monkeys either untreated (control) or for Parkinson's Disease injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; via unilateral intracarotid artery infusion). To maintain age as the pri-S. G. Kamath, D. Lee, M. N. Gordon, and D. Morgan mary variable, all MPTP animals were treated until the same level of behavioral impairment, complete disuse of the contralateral forelimb Alzheimer's Research Laboratory and Department of Molecular and hand, was observed. Three months after the onset of these behav-Pharmacology and Physiology, University of South Florida, ioral impairments, the brains were collected for analysis. Microglia Tampa, FL, USA were identified using immunohistochemical techniques for the HLA-DR complex (an antigen presenting complex). Using unbiased stereological quantification of microglia number, we show significant and The progressive loss of dopaminergic neurons in substantia nigra similar age-related increase in the number of microglia in all three pars compacta (SNpc) seems to be underlying cause of Parkinson's DAergic subregions. Following MPTP, further significant increases in disease (PD). Current drug therapy has time-limited usefulness to the the number of microglia were observed in all regions at all ages. Thus, patient. Many neuroprotective strategies are limited by the requirement age-related changes in the number of microglia in control animals are for intracranial administration to be effective. This is true for the neunot sufficient to explain the regional differences in susceptibility to roptrophic factors that are proposed to protect dopaminergic neurons degeneration among DA neurons. Moreover, the changes in the numas well as proteinaceous anti-inflammatory agents. In addition to cost ber of microglia in response to MPTP at different ages do not adeconsiderations, there are risks associated with these surgical intervenquately provide evidence for the involvement of microglia number in tions. Therefore, development of minimally invasive therapy, such as regionally different responses to MPTP during aging. Ongoing studies ex vivo gene therapy, to arrest disease progression by delivering genes will determine the regional distribution and age-related alterations in or trophic factors could be a therapy of choice for the general populathe number of astrocytes. tion. Recently, it was shown that circulating monocytes, the precursors Supported by AG17092 and the Millennium Scholars Fund of the of tissue macrophages, can traffic into brain (much like other tissues)
University of Cincinnati (T.J.C.). and become associated with sites of tissue injury and inflammation, suggesting that they may also be capable of transporting beneficial genes to areas of tissue injury in the brain. The goal of this research is Striatal Grafts: Fetal Neural Precursors Yield More Extensive to investigate the potential of cell-based therapies to protect dopamine Fiber Outgrowth Than Primary Fetal Cells in Both Allograft neurons from toxicity caused by 6-hydroxydopamine (6-OHDA). To and Xenograft Enviroments generate nigrostriatal neurodegeneration, mice received either 8 µg of 6-OHDA free base dissolved in 2 µl of 0.9% saline containing 0.01% C. M. Kelly,* S. Precious,* R. Penketh, † N. Amso, † A. Rosser,* ascorbic acid or vehicle via stereotaxic injections into the right striaand S. Dunnett* tum using a 10-µl Hamilton syringe with a 26-gauge needle tip. The solution was infused at a constant rate of 0.5 µl/min. Separately, *School of Biosciences, Cardiff University, Cardiff, Wales, UK CD11b-positive monocytes were harvested from the bone marrow of C57BL/6-Tg(ACTB-EGFP)1Osb/J mice that express enhanced green †Department of Obstetrics & Gynaecology, Cardiff University, fluorescent protein (EGFP) using magnetic cell separation. Twenty-Cardiff, Wales, UK four hours post-6-OHDA lesion, mice received freshly prepared 5 × 10 6 CD11b (EGFP+) cells via tail vein injections. Animals were sacri-Human fetal striatal xenografts have been reported to give rise to more extensive fiber outgrowth in the rat striatum than do rat striatal ficed 4 days after monocyte injection, and brains were processed for allografts. There are at least three possible explanations: (i) artefactual later the animals were analyzed with immunohistochemistry for evidence of mNSC migration and effects on tau. Tau-labeled granules in effects, such as due to there being more sensitive labels available for cross-species grafts (e.g., using antibodies against human-specific neu-cluster formation were seen throughout the hippocampus, olfactory bulbs, and occassionally evident within the amygdala, cerebellum, and rofilaments) than are available for tracing the connections of allografts; (ii) scaling effects, such as the developmental outgrowth of human pontine gray of both DS and diploid mice. The vast majority of these granules were extracellular and located in regions with neuronal axons cells is greater than rat cells whatever the environment to which they are transplanted; (iii) a real advantage of xenotransplantation, such as and dendrites. DS mice had a greater number of tau cluster formations (mean 23 ± 3.6) compared with diploid controls (mean 7 ± 3.5) within there being inhibitory factors that are species specific and hence do not affect xenografts.
the hippocampus [F(1, 20) = 10.49, p = 0.004], primarily in region CA1. The size of the hippocampal tau clusters was not different be-We have compared fiber outgrowth from human and mouse striatal grafts, implanted as either primary fetal (PF) tissue or 10-day ex-tween DS and diploid mice. The 1-month treatment effect of mNSC did not significantly alter the number or size of the hippocampal tau panded fetal neural precursors (FNPs) into the quinolinic acid-lesioned mouse and rat striatum. Fiber outgrowth was analysed postmortem us-clusters in aged DS mice. Implantation of mNSC into diploid mice significantly reduced the size of hippocampal tau clusters [F(1, 19) = ing a variety of different donor-specific labels (GFP transgenic donors, LacZ-lentivirus labeling in vitro, human-specific neurofilament anti-5.76, p = 0.03], although no discernible effect on the number of tau clusters was detected. Interestingly, the act of penetrating the DS bodies) and tracer methods (BDA, neurobiotin, Pha-L). Xenografts were immunoprotected by daily injection of 10 mg/kg cyclosporin A.
brain, regardless of whether mNSC or saline was infused, significantly reduced the number of hippocampal tau clusters [F(1, 20) = 9.39, p = As with previous rat-to-rat allografts, the survival of mouse-to-mouse allografts was higher (94%) than of mouse-to-rat (78%) or human-to-0.006]. This finding was unique to DS mice as no significant effects were evident in diploid controls. There was neither a genetic effect rat (81%) xenografts. Fiber outgrowth was consistently higher from FNPs than from FP striatal grafts irrespective of donor source and host (DS vs. diploid mice) nor a treatment effect (mNSC vs. saline infusion) in number of olfactory tau cluster formations. The elevated num-environment. Human cells grew more extensively than mouse tissues in the xenograft environments, whereas mouse tissue showed similar ber of hippocampal tau clusters in aged DS mice is consistent with and may actively contribute to their previously described cognitive pattern and extent of outgrowth in both allograft and xenograft environments.
impairment with specific reference to deficits in learning and memory. The act of penetrating the brain has been shown to trigger the release These results indicate: (i) that we have succeeded in controlling for differences in labeling methods; (ii) there is a major species differ-of growth factors, which may have contributed to the alterations of hippocampal tau granules in cluster formation. ence in the extent of fiber outgrowth from striatal grafts that correspond to species differences in developmental growth; (iii) the cell Support: RO1 HD045224 to K.N.M., St. John's Trust, and a gift from Marilee and Ben Doud, Evergreen, CO; and the Anna & John preparation protocol is important, FNPs having a greater capacity for fiber growth than PF tissues; and (iv) although failure of immunosup-J. Sie Foundation. pression clearly did compromise the survival of a minority of xenografts, there were no detectable differences between the extent or pattern of fiber outgrowth of surviving grafts in the allograft and Immunological Properties of Umbilical Cord Blood-Derived xenograft environments.
Mesenchymal Stem Cells As a corollary, we can also conclude that studies of human fetal cells transplanted into the rat or mouse striatum do provide a valid groups should also communicate effectively with the patient community that will become the research subjects or beneficiaries of their Recent study suggests that stem cells are useful gene delivery vehiresearch. Increasingly, media reports on the promise of early research cles for brain tumor therapy. Human umbilical cord blood-derived findings, and the formation of interdisciplinary research efforts aimed mesenchymal stem cells (hUCB-MSCs) are particularly attractive for at particular disorders, have led to heightened but unrealized expectaclinical use because they are easily isolated, can be expanded in cultions for rapid development of clinical trials. This attention, and fundture, and can be genetically manipulated. Tumor necrosis factor ing that may accompany it, brings with it a responsibility to develop (TNF)-related apoptosis-inducing ligand (TRAIL) has been shown to realistic plans and prospective milestones for translation. The ASNTR induce apoptosis in a wide variety of cancer cells and to suppress has played a leadership role in developing and publishing guidelines tumor growth specifically without damaging normal cells and tissues.
for clinical studies of neural transplantation and repair (Cell Trans-We hypothesized that hUCB-MSCs may have a tropism for brain tuplant. 10:661; 2001) . This effort has influenced others, including mors and thus could be used as TRAIL gene delivery vehicles for guidelines developed recently by the spinal cord injury community glioma therapy. For the TRAIL-based cancer gene therapy, we devel-(Spinal Cord, in press). Presently, the development and regulation of oped an adenoviral vector delivering the gene that encodes our secretaclinical testing of cellular and other biologic therapeutics (such as gene ble trimeric TRAIL (stTRAIL). Human mesenchymal stem cells therapy) remains a rapidly evolving area and thus it warrants ongoing (hMSCs) were transduced with an adenoviral vector carrying the discussion. One key issue yet to be addressed is the designation of stTRAIL gene (hMSC-stTRAIL). The migratory ability of hMSCs was effective preclinical tests or models to predict both probable benefits confirmed by an in vitro migration assay, and showed in vivo by inand potential dangers of novel therapeutics. Other issues include disjecting hMSCs into the hemisphere opposite to an established human cussions of the effective use of large animal and nonhuman primates glioma in nude mice. In vitro, coculture and Transwell experiments in preclinical testing, how to test combination therapies (e.g., cells plus showed the efficacy of hMSC-stTRAIL against human gliomas. In trophic factors, drugs, and/or novel delivery devices), and the need vivo experiments showed that intratumoral injection of hMSCfor replication of critical preclinical results. Clinical issues include the stTRAIL significantly inhibited tumor growth and increased the surselection of appropriate outcome measures, the ethics and necessity of vival of U87 glioma-bearing mice compared with controls. These resham surgical controls, and how to evaluate clinical use of untested sults show that the potential use of hUCB-MSCs as delivery vehicles cellular therapies and respond to the inquiries such practices attract for glioma therapy for the first time, and that this tropism of hMSCs from our patient communities. Both private and public funding agenfor human gliomas can be exploited to therapeutic advantage.
cies have responded to the evolving need for research efforts aimed at translation by developing programs to nurture translational efforts (e.g., Nat. Neurosci., Tampa, FL, USA therapy and cortical stimulation that have begun so show promise in †Mayo Clinic Jacksonville, Jacksonville, FL, USA some clinical populations. Additional studies have demonstrated the efficacy of various pharmacological and sensory stimulation interventions in enhancing recovery in animal models of stroke but remain to Pathologic protein accumulation is a primary component of several neurodegenerative diseases. The microtubule-associated protein tau be tested in human patients. Despite the promise of animal models for developing putative interventions, the historical disconnect between aggregates into abnormal fibrils in several such diseases, including Alzheimer's and Parkinson's diseases as well as a host of other rarer basic and clinical stroke research has resulted in a failure for animal research to sufficiently address several fundamental issues. These in-diseases classified as tauopathies. The formation of these tau aggregates is dependent upon aberrant hyperphosphorylation and collec-clude identifying the impact of treatment during the acute versus chronic phase of recovery, differential effects of cortical versus sub-tively the process is closely linked to neurodegeneration. Expediting the removal of these phospho-tau species may be a highly relevant cortical stroke, and the importance of training intensity. The utility of animal models will be discussed and suggestions for future basic and therapeutic stratagem. We have shown that pharmacologic inhibition of the ATPase activity of Hsp90 degrades phospho-tau independent of clinical research directions will be proposed. de novo chaperone transcription by heat shock factor-1. Therefore, potential involvement in expression of the crossed phrenic phenomenon. If these cells are found to contribute to plasticity following SCI, we have begun investigating the mechanisms used by the constitutive chaperone complex to facilitate the removal of abnormal phospho-tau.
they may act as a target for promoting repair. Enhancing the extent of plasticity following cervical SCI may improve long-term functional This complex typically works in concert with various interchangeable components (i.e., E3 ubiquitin ligases, prolyl isomerases, etc.) culmi-outcomes and reduce respiratory related mortality following injury. Supported by NIH (5RO1NS54025). nating in either complete or partial refolding of the substrate, or its degradation. While several components specifically involved in phospho-tau degradation have been identified (i.e., CHIP, Hsp70, Hsp27, etc.), we have found that the refolding cochaperone, P23, may also Bone Marrow-Derived Monocyte as Gene Therapy Vectors regulate tau biology, acting rather to prevent its degradation. This infor the Treatment of Alzheimer's Disease teraction would provide new evidence that AD pathogenesis is due in part to the misfolding of the inherently linear tau protein, an event L. A. Lebson, S. G. Kamath, D. Morgan, and M. N. Gordon perhaps precipitated by amyloid accretion. In these studies, we have expanded our search for other cochaperones typically involved in pro-Alzheimer's Research Laboratory and Department of Molecular tein refolding that may also modify tau biology. We have also further Pharmacology and Physiology, University of South Florida, investigated the impact of the small heat shock protein, Hsp27, on tau Tampa, FL, USA biology, demonstrating that this small chaperone may be modified by the same signaling cascades that are implicated in tau hyperphosphorylation during disease progression. Hsp27 binds to tau in Alzheimer's
Monocytes are blood mononuclear cells expressing surface markers CD11b, CD11c, and CD14 in humans and CD11b and F4/80 in disease, and it also functions to regulate the cytoskeleton through manipulating actin. The recent demonstration that actin aggregation facil-mice and devoid of other lymphoid cell markers. They are produced by the bone marrow, circulate in the blood for few days, and respond itated by tau accumulation is linked to neurodegeneration, a process that is also enhanced by AD, further suggests an important role for to proinflammatory cues, migrate to inflamed tissues, and differentiate into macrophages and dendritic cells (DCs). Recent data suggest that Hsp27 in the pathogenesis of Alzheimer's disease as well as other tauopathies.
circulating monocytes, the precursors of tissue macrophages, can traffic into brain (much like other tissues) near sites of tissue injury and inflammation. Increasingly, it appears that the bulk of activated macrophages near sites of brain injury actually derive from these circulating campus. An additional group of mice received 2 µl of saline into the right hippocampus and served as the control. Animals were sacrificed respiration. It has been shown, however, that some respiratory recovery can occur even following experimental injuries at high cervical 1, 4, 7, and 14 days following intracranial injections. This model allowed us to observe the trafficking of monocytes within the adult spinal levels that interrupt descending bulbospinal inspiratory drive to the spinal phrenic nucleus at C3-C5/6. For example, after a C2 CNS. Fluorescent immunostaining for CD11b and anti-GFP qualitatively demonstrated that a much greater percentage of monocytes were hemisection, phrenic motor neurons (PhMNs) ipsilateral to the injury can exhibit a small degree of spontaneously recovered neurophysiolog-able to cross the blood-brain barrier and migrate to the injection site in response to the MCP-1/RANTES signal compared with mice receiving ical activity despite the absence of any restored supraspinal inputs on the side of the injury. This appears to be mediated by activation of a intracranial saline injections. The migration of monocytes was also observed in the transgenic amyloid depositing APP/PS1 mouse model. latent crossed midline pathway (i.e., the crossed phrenic phenomenon, CPP) from undamaged, descending contralateral respiratory bulbo-Five million CD11b+ monocytes were injected into 9-month-old double transgenic mice into the tail vein every 4 days for a total of three spinal projections. It is presently thought that the underlying neural circuitry simply involves monosynaptic projections of decussating col-times and the mice were sacrificed 3 days after the last tail injection. Fluorescent immunostaining for CD11b and anti-GFP demonstrated laterals onto the ipsilateral PhMNs. In the rat, interneurons premotor to PhMNs are believed not to exist. However, recent neurophysiological that monocytic CD11b+ cells were able to cross the blood-brain barrier and home to Aβ plaques in the Alzheimer disease transgenic studies (Sandhu et al., Soc. Neurosci. Abstr. 447.3; 2006) suggest that premotor interneurons may be involved in the CPP observed following mouse model compared to the control mice. Long-term studies are under way to monitor the migration and differentiation of neprilysin C2 hemisection. The present study thus used a combination of immunocytochemistry and neuroanatomical tracing to further examine the transfected monocytes into macrophages, and subsequent effects on amyloid in transgenic mouse models of amyloid deposition. neural circuitry involved in respiration and how this may be modified following SCI. Cholera toxin b (CTb, neuronal tracer) and pseudora-Supported by AG 15490. bies virus (PRV, transneuronal tracer) were used to retrogradely label the PhMN pool and to identify (PRV) the temporal infection of second-order neurons in the cervical spinal cord. For this purpose, the Age-Related Classical and Alternative Activation of Microglia ipsilateral diaphragm in uninjured and C2 hemilesioned rats (1-4 in Mouse CNS weeks postinjury) was exposed to these tracers by either injection or topical application of tracers to the diaphragm 48-72 h prior to sacri-D. C. Lee, L. Lebson, M. Mercer, D. Morgan, and M. N. Gordon fice. The extent and distribution of targeted PhMN labeling was comparable between these methods. Results to date demonstrate the ap-Alzheimer's Research Laboratory and Department of Molecular pearance of second-order PRV-infected neurons near the midline of Pharmacology and Physiology, University of South Florida, the ipsi-and contralateral spinal cord that were first seen at 60-63 h Tampa, FL, USA when no other infected cells were present. The size and location of these cells in the region of Rexed lamina 7 are consistent with these cells being interneurons. Further work is under way to more clearly Macrophages/microglia have been shown to possess at least two polarized states. The classical or M1 response results in tissue damage, define the identity of these premotor cells, their innervation, and their 332 ABSTRACTS inflammation, and pathogen destruction, whereas the alternative or M2 *Department of Psychiatry, Yale University School of Medicine, response leads to tissue repair and suppression of inflammation. Identi-New Haven, CT, USA fying the various activation states of microglia has been difficult be- †Department of Obstetrics, Gynecology, and Reproductive Sciences, cause of defining markers, age-related responses, and variable stimuli.
Yale University School of Medicine, New Haven, CT, USA Understanding the dynamic states of microglia during neurodegenera- ‡Department of Pharmacology, University of North Carolina, tive disorders may help elucidate the disease course and understand Chapel Hill, Chapel Hill, NC, USA repair mechanisms. In these studies we performed intraparenchymal §Department of Neurosurgery, Yale University School of Medicine, injections into the hippocampus (HPC) and anterior cortex (ACX) with New Haven, CT, USA different cytokine cocktails designed to selectively elicit either an M1 ¶Ecole Polytechnique Fédérale de Lausanne, Switzerland or an M2 bias into young (6 months), middle (12 months), and aged (24 months) mice. The M1 cocktails comprised of TNF-α, and In several animal studies, signs of Parkinson's disease (PD) could IL-1β, whereas the M2 cocktails consisted of IL-13 and IL-4. Several be improved by injecting GDNF into the basal ganglia. However, the markers evaluated included CD45, F4/80, MHCII, FCγ R, and YM1 one controlled clinical study showed lack of statistical efficacy, and a (a chitinase, often induced by parasitic infections; typically considered potential for cerebellar toxicity was noted in a study in primates. More an alternative activation marker). Results from these studies show an selective delivery of GDNF by viral vectors might be more efficacious aged-related and selective response to the marker and stimuli adminisand less likely to produce toxicity at distant sites. The duration of tered. CD45, F4/80, and YM1 were expressed in the cortex and hippogene expression after viral vector delivery is also an important safety campus following classical activation of microglia in young, middleconsideration for vectors without regulatory promoter systems, alage, and aged mice. The M2 cocktail induced YM1 expression in though long-term expression might be necessary for them to be effecyoung and middle-aged mice only. Thus, as evaluated by YM1 exprestive long-term treatments. We compared the single-stranded DNA parsion, alternative activation of microglia is lost in the aged mice. This vovirus adeno-associated virus (AAV), serotype 2, a widely used suggests that in aged mice, the intact classical activation response is vector for gene delivery, to the lentivirus equine infectious anaemia unopposed by alternative activation mechanisms, which may result in virus (EIAV), with both vectors expressing the human gene for gliala greater tendency towards inflammatory reactions in the aged brain.
derived nerve growth factor (GDNF). Both vectors were used to de-Supported by AG15490 and AG04418.
liver transgene to the caudate, putamen and substantia nigra of St. Baton Rouge, LA, USA mals treated with MSCs transplantation (group 1) compared to animals transplanted with PGA scaffold without cells (group 2) or control ani-Amyloid beta peptide extracellular deposition has been identified mals (group 3). In histological analysis, evidence of axonal regeneraas pathogenic hallmark of Alzheimer's disease. However, what trigtion into the newly formed tissue at the gap was found in animals gers the aggregation and deposition of AB in the brain is still unclear. treated with MSCs transplantation (group 1), but very weak or no evi-In our peptide-based inhibitor study, we unexpectedly found that dence of axonal regeneration was found in group 2 and group 3 ani-17,19,21-tri-N-methyl-Abeta(16-22) increased AB deposition. Nmals. These data suggest that transplantation of MSCs may have a methyl AB core peptide 0.3 nmol in 2 µl PBS was injected into right therapeutic role after spinal cord injury.
Kitts green monkeys (Chlorocebus aethiops sabaeus). GDNF was Functional Recovery After Bone Marrow Stromal Cell
hippocampus of APP Tg 2576 mice at age of 14 months. After 7 days, the brain tissues were collected for immunohistochemistry to detect AAV2 Is Superior to EIAV Vector for Expressing GDNF total AB and Thioflavin-S to measure AB compact plaques. The rein the Primate Nigrostriatal System sults showed that total AB was significantly increased in the hippocampus ipsilateral to the injection compared to the contralateral hippocampus when injecting the core peptide, but not when injecting the S. W. Leichtle,* J. Bober, † E. A. Markakis,* C. Leranth, † R. J. Samulski, ‡ X. Zhou, ‡ R. Zufferey, ¶ P. Aebischer, ¶ PBS vehicle. A similar trend was apparent for the THIO-S staining of the compact plaques. There was no difference in either diffuse AB or K. Vives, § and D. E. Redmond, Jr.* § compact plaques in anterior cortex on either side. Therefore, our data for stem cell-based regenerative medicine to treat neurological disorders. It has been recently reported that mouse bone marrow-derived indicate that N-methylated AB core peptide is a fibril-promoting compound that induces deposition of AB in the brains of mice over-MSCs have a spontaneous neural differentiation potentiality. In the current study, to evaluate and enhance the neural potentiality of umbil-producing human AB. Additional studies will investigate possible mechanisms of the peptide's action.
ical cord blood-derived MSCs, we used BDNF in culture of MSCs, which is known to play a key role in differentiation, development, and Supported by NIH grants AG18478 and AG20227.
survival of neural stem cells. Treatment of cells with BDNF surprisingly increased the spontaneous expression of certain neuronal pheno-Effects of Mucuna pruriens Extract on Drug-Induced Dyskinesias type markers in culture, in the absence of specialized induction rein Hemiparkinsonian Rats agents, compared to the BDNF nontreated MSCs. In addition, neural differentiation-related Raf-ERKs signaling pathways were strongly enhanced in the BDNF-treated cells. Also, when grafted into the lateral C. A. Lieu,* J. E. Nyland,* N. J. Wiley,* A. M. Stull,* ventricles of neonatal mouse brain, BDNF-treated MSCs survive and K. Venkiteswaran,* B. V. Manyam, † and T. Subramanian* migrate more extensively, and strongly differentiate into olfactory bulb granule cells and periventricular astrocytes. These results indicate that *Penn State University Hershey Medical Center, Hershey, PA, USA BDNF may be an effective factor for neural differentiation of UCB- †Texas A&M University College of Medicine, Temple, TX, USA derived MSCs, and also BDNF could be a potential agent when performing stem cell transplantation therapy for treating central nervous Drug-induced dyskinesias (DID) are a common late complication system injuries. in advanced Parkinson's disease (PD) patients. The Indian Ayurvedic medicine, Mucuna pruriens, has been shown to ameliorate parkinsonism in animal models of PD and human PD patients. However, its antidyskinetic effects in animal models of PD have not been fully ex-Examination of the Therapeutic Potential of an Engineered plored. We tested the effects of Mucuna pruriens extract (MPE) in the VEGF-A Transcription Activator in a Spinal Cord Injury Model 6-OHDA-induced hemiparkinsonian (HP) rat model of PD for DID. HP rats were injected with L-dopa (8 mg/kg) and benserazide (15 mg/ Y. Liu,* S. K. Spratt, † G. Lee, † D. Ando, † and M. G. Fehlings* ‡ § kg) to induce DID and videotaped using previous rating methods to analyze the frequency and intensity of dyskinetic movements (Cenci *Toronto Western Research Institute, Toronto, Canada et al., Steece-Collier, et. al.) . After drug washout, the same animals †Therapeutic Development, Sangamo BioSciences, were exposed twice daily to MPE L-dopa equivalent dose (calculated Richmond, CA, USA based on biochemical L-dopa content in natural Mucuna pruriens endocarp powder) + benserazide (15 mg/kg). MPE was obtained as an ‡Krembil Neuroscience Centre, University Health Network, extract and administered as injections as opposed to oral administra-Toronto, Canada tion of its natural form in our previously reported human and primate §Division of Neurosurgery, University of Toronto, Toronto, Canada studies. To obtain a dose-response curve, we further tested fractions of this original dose on the same animals. DID were rated by three Spinal cord injury (SCI) results in the initiation of multiple secondindependent raters and scores were averaged for the analysis. Dyskineary injury cascades, one of which is the disruption of spinal cord blood sia composite rating score was 3.80 after L-dopa treatment and 4.37 flow and the onset of spinal cord ischemia. Vascular endothelial after MPE treatment at L-dopa equivalent dose (rating scale = 0-9; Int. growth factor (VEGF) is a major regulator of endothelial cell prolifer-× Freq.). Further, dose-response data showed that rats injected with ation, angiogenesis and vascular permeability, a potent neurotrophic lower amounts of MPE have lower dyskinesia composite scores and factor and glial cell growth factor. An engineered zinc finger protein appeared to ameliorate parkinsonism adequately. At MPE doses that transcription factor (ZFP-TF) was designed to activate expression of were 1/4, 1/2, and 3/4 fractions of the original L-dopa equivalent dose, all the isoforms of the endogenous VEGF gene for complete biological the dyskinesia rating scores were 0.25, 1.06 and 5.58, respectively. function. The engineered ZFP-TF upregulates the endogenous VEGF These novel data suggest that MPE may be a potent antiparkinsonian gene in multiple cell lines, including cells of neuronal origin. In additherapeutic agent and that lower doses of MPE may be sufficient to tion, conditioned medium from cells expressing the ZFP-TF is neuroprovide antiparkinsonian behavioral benefits without causing deleteriprotective against a serum starvation insult in neuroblastoma cell lines. ous side effects like DID. Alternately, MPE or the parenteral adminis-Furthermore, a single intramuscular injection of a plasmid formulation tration of MPE may not provide the anti-DID properties of orally adcontaining the ZFP-TF results in improvements in sensory and motor ministered natural Mucuna pruriens that have been previously nerve conduction velocities in a streptozotocin-induced diabetic rat reported. Future experiments will examine the antiparkinsonian effects model of diabetic neuropathy. Diabetic neuropathy is a progressive of oral and parenteral MPE versus oral Mucuna pruriens in its natural nerve degeneration that occurs in over half of patients with diabetes form and their effects on DID.
( In the injured spinal cord area 10 days after SCI and treatment, using *Department of Neurosurgery, The Catholic University of Korea, immunohistochemistry, a significant increase in vascularization (as-Seoul, Korea sessed by RECA-1 immunostaining) and decreased levels of apoptosis †MEDIPOST Biomedical Research Institute, Pungnap-2dong, (assessed by TUNEL) occurred in rats treated with AdV-ZFP-VEGF compared with controls. Our findings suggest that this engineered Songpa-gu, Seoul, Korea ZFP-VEGF-activating transcription factor led to upregulation of VEGF protein, protection/repair of blood vessels, and decreased apo-Reports of neural transdifferentiation of mesenchymal stem cells (MSCs) suggest the possibility that these cells may serve as a source ptosis. These data suggest that VEGF gene therapy using a ZFP tran-334 ABSTRACTS scription factor plasmid holds promise as a therapy for SCI and other siHUNT-1) to 7-day-old wild-type and R6 transgenic HD mice, analyzed the behavior of the mice over an 8-month-period, and deter-forms of neurotrauma.
mined the effect of this treatment on gene expression. Surgery and delivery of rAAV5 to 7-day-old mouse pups resulted in limited transduction of neurons in the striatum, cortex, hippocampus, and hypothal-Long-Term Vitamin E Supplementation Reduces Cognitive amus but did not cause astrogliosis or any abnormal behavior. The Deficits in the Ts65Dn Mouse, a Model for Down Syndrome onset of mutant huntingtin-induced hindlimb clasping was delayed by rAAV5-siHUNT-1 treatment, although this treatment did not reverse J. P. Lockrow, K. Sambamurti, and A.-C. Granholm deficits in weight gain or rotorod performance observed in R6 transgenic HD mice. Low-level expression of rAAV5-siHUNT-1, despite Department of Neurosciences, Medical University of South Carolina, slowing the development of hindlimb clasping, did not reverse tran-Charleston, SC, USA scriptional deficits; it appears that the treatment of 7-day-old pups resulting in limited transduction and low per neuron expression of si-Individuals with Down syndrome (DS) exhibit the neuropathology HUNT-1 was comparable to transduction of a greater number and of Alzheimer's disease, including progressive degeneration of basal higher per neuron expression of siHUNT-1 in adult mice. It is possible forebrain cholinergic neurons (BFCNs), comparatively early in life.
that increasing the number of neurons transduced and the intracellular Impaired cholinergic signaling mediates some of the cognitive impairexpression of siHUNT-1 beginning in the postnatal period may signifiments seen in DS, and contributes to Alzheimer's-like dementia. One cantly delay the onset of abnormal HD-like behavior in R6 mice. Cursuspected contributor to BFCN degeneration is oxidative stress, which rently, we are testing alternate AAV serotypes to increase efficacy of is increased both in DS and in an animal model for DS, the Ts65Dn early postnatal transduction and the effects of knock-down of mutant mouse. In order to determine whether antioxidant therapy can suppress huntingtin in a mouse knock-in model of HD. this increase in oxidative stress and prevent cholinergic degeneration and its cognitive repercussions, Ts65Dn mice received a diet supplemented with the lipid-soluble antioxidant vitamin E. This vitamin E therapy began at 4 months, an age prior to appreciable cognitive defi-
The Immune Response to Intracerebral Recombinant Adeno-Associated Virus Administration cits in this model, and continued until they were 8 months of age. We report that a diet supplemented with 400 IU/kg vitamin E reduced markers of oxidative stress in the Ts65Dn brain to the level of the R. S. Mandel, S. Reimsnider, F. Manfredsson, C. Peden, littermate controls, and further, significantly reduced BFCN atrophy N. Muzyczka, and C. Burger in the medial septal nucleus. In addition, vitamin E markedly enhanced the Ts65Dn performance in the radial arm water maze, as the treatment Department of Neuroscience, Powell Gene Therapy Center, reversed deficits in both working and reference memory at 8 months McKnight Brain Institute, University of Florida College of Medicine, of age. This study further supports the role of oxidative mechanisms Gainesville, FL, USA in the neurodegeneration seen in DS and the use of vitamin E supplementation as a safe and potentially viable means of reducing this oxidative stress and its associated cognitive decline.
A single intracerebral injection of rAAV vectors in animals in-Supported by USPHS grant AG12122 and a grant from the Sie duces little or no immune response, especially if the transgene is syn-Foundation.
geneic. However, when the animal has been preexposed to either rAAV or wt-AAV, then the immune system is capable of a vigorous response in the brain. We reported previously that peripheral preimmunization of rats can completely block striatal transduction of rAAV2-rAAV-Mediated Delivery of siRNA in the Early Postnatal R6/1 GDNF (Peden et al., 2004) . In that study, we also showed no reduction Mouse Model of Huntington's Disease of transgene expression in response to striatal readministration even though there was an immune response consisting of monocyte infiltra-R. J. Mandel,* A. S. Lewin,* E. A. McCaw, † tions, astrocytic response, MHC-1 expression, and T-cells in the secand E. M. Denovan-Wright † ond injection site. Subsequently, we have shown that readministration of rAAV2-GFP with an interval of 2 or 4 weeks leads to a 70% loss *Department of Neuroscience, University of Florida, of transduced striatal neurons. These data indicate that brain injection Gainesville, FL, USA of rAAV2 can result in antigen presentation and activation of the im- †Department of Pharmacology, Dalhousie University, mune system. Because there are no viral genes remaining in rAAV, Halifax, Canada the identity of the peptides presented on the cell surface is either the transgene or the remnants of the rAAV capsid after uncoating (Lowenstein, 2005) . Indeed, reports indicate that different rAAV serotypes Huntington's disease (HD) is a progressive neurodegenerative disorder that is caused by the expression of one mutated copy of the gene uncoat at different rates. Thus, we have studied longer intervals between rAAV2 readministrations and whether a different rAAV sero-that encodes the protein huntingtin. Inheritance of one copy of the HD gene with an extended CAG repeat leads to the expression of hunting-type can be safely readministered. We have found that rAAV5 can be successfully readministered with no loss of transduced cells and that tin with an extended polyglutamine region. Over a period of years, expression of mutant huntingtin leads to changes in neuronal pheno-increased intervals between rAAV2 administrations is also nontoxic. These data support the idea that it is the rAAV2 capsid peptides that type and function throughout the brain and, eventually, death of some subpopulations of neurons such as the medium spiny GABAergic pro-are presented via MHC-1 expression and not the xeno-transgene, GFP.
We then asked whether onset of transgene expression is affected by jection neurons. Previously, we demonstrated that lowering levels of mutant huntingtin starting in adult presymptomatic transgenic HD differing uncoating rates. We injected rAAV1, rAAV2, rAAV5, and rAAV8 and evaluated striatal GFP+ neurons at 4, 7, 14, 28, days and mice modestly delayed the onset of abnormal motor symptoms. In these initial studies, we used R6 mice that express a full complement 9 months. We found that rAAV1 and rAAV2 mediate GFP expression in the same number of cells starting at 4 days posttransduction (which of mouse huntingtin and the amino-terminus of human huntingtin with different lengths of polyglutamine repeat. Because future HD patients is far more rapidly than previously thought). In contrast, rAAV5 and rAAV8 ramp up their expression of GFP over a 2-week period even can be identified at birth, it is possible that lowering levels of mutant huntingtin from the early postnatal period would be more effective at though rAAV5 and rAAV8 uncoat more rapidly than rAAV1 and rAAV2. We also showed that there is an astrocytic and microglial slowing mutant huntingtin-induced changes in neurons compared to lowering levels after a period of accumulation of mutant huntingtin. response to all rAAV serotype injections that wanes over 9 months. We conclude that there are immune responses in the brain in response To test this hypothesis, we delivered adeno-associated viral vector (subtype 5) expressing an anti-human huntingtin siRNA (rAAV5-to rAAV injections. However, with knowledge of the characteristics of these immune responses, the safety of rAAV injections can be suc-later, all rats received a four-site intrastriatal injection of a total of 28 µg 6-OHDA in 8 µl of ascorbate-saline solution as previously de-cessfully managed.
scribed (Kirik et al., Exp. Neurol. 152:259-277; 1998) . Starting 4 weeks after the 6-OHDA injection, the experimental animals were tested once per month for 3 months on amphetamine-induced rota-rAAV-Mediated Knock-Down of Tyrosine Hydroxylase tional behavior, the cylinder test, and forelimb stepping (only months in the Substantia Nigra Using a Pol II Transcribed siRNA 2-3). Nigral overexpression led to a significant reduction in amphetamine-induced rotational behavior (−67% compared to controls, by 3 F. P. Manfredsson, C. Burger, N. Muzyczka, A. S. Lewin, months after 6-OHDA injection). Spontaneous limb use in the cylinder and R. J. Mandel test was also positively affected because control rats used their affected limb approximately 10% of the time while parkin-treated rats Departments of Neuroscience and Molecular Genetics and used their affected limb slightly more than 20% of the time. Finally, Microbiology, McKnight Brain Institute, Powell Gene Therapy forelimb akinesia as measured by the stepping test was unaffected. We Center, Movement Disorders Center and the Genetics Institute, have subsequently replicated these data with another group of 20 ani-University of Florida College of Medicine, Gainesville, FL, USA mals. Unbiased estimation of nigral DA cell numbers reveals no difference between the two groups. On the other hand, striatal DA levels were reduced to 8% of normal in the control rats while parkin-treated The use of small interfering RNA (siRNA) has become increasrats had 18% of striatal DA remaining (p = 0.06). Our data indicate ingly popular in recent years for gene knockdown both in vivo and in that specific nigral overexpression of human parkin is partially neurovitro. To date, a majority of expression systems are utilizing a RNA protective at the functional level against a strong toxic stimulus, intrapol III promoter. The pol III promoter, although supporting high levels striatal 6-OHDA. These data suggest that enhanced ubiquitin-mediated of siRNA expression, cannot be easily regulated nor engineered to clearance of damaged proteins is protective against a nonspecific insult confer tissue specificity. In this study, we utilize recombinant adenoin nigrostriatal dopamine neurons. associated virus (rAAV) to express siRNA targeting tyrosine hydroxy-This study was supported by a joint National Parkinson's Disease lase (TH), a protein involved in the production of dopamine, using an Foundation and Parkinson's Disease Foundation Research Grant. expression cassette containing the chicken β-actin (CBA) pol II promoter. The siRNA hairpin sequence is flanked both upstream and downstream by self-cleaving ribozymes that serve to liberate the tran-Separate rAAV1 Vectors Co-Infect Striatal Neurons script. Downstream of the cassette is an IRES-GFP to serve as control at High Efficiency for transduction and siRNA expression. In addition the nature of the expression cassette should prevent toxicity associated with high levels of siRNA expression due to interference with small RNA transport. F. P. Manfredsson, A. C. Rising, and R. J. Mandel The virus was injected unilaterally in the substantia nigra of adult rats and immunohistochemical evaluation indicate that transduced cells ex-Neuroscience, McKnight Brain Institute,University of Florida press significantly reduced levels of TH, whereas nontransduced cells College of Medicine, Gainesville, FL, USA have normal TH levels. However, to date we have not observed significant amphetamine-induced asymmetrical behavior. In addition, we rAAV is a useful tool for gene therapy; however, because of the expressed the same siRNA cassette under the control of the doxycylimited size of the AAV genome, large or multicistronic cDNAs are cline responsive promoter pTight. In vitro transfection studies indicate problematic. For example, the tetracycline responsive promoter-transa significant reduction of TH in the presence of doxycycline and transactivator transcriptional regulation system is difficult to package in a activator plasmid as compared to controls. single rAAV vector. In instances where more than one gene is required, co-infection by two viruses is necessary and, often, both genes must be transferred to the same cell for the system to function prop-rAAV-Mediated Nigral Parkin Overexpression erly. To date, the rate at which two mixed viral vectors infect the Is Neuroprotective in the 6-OHDA Rat Model same cells has not been quantified. We hypothesized that a sequential of Parkinson's Disease surgical procedure separated by 24 h would allow for receptor recycling and increase the number of double hits. Six adult rats were injected F. P. Manfredsson, C. Burger, N. Muzyczka, A. A. Lewin, unilaterally in the striatum with a mix of AAV1-GFP and AAV1 DSand R. J. Mandel
Red2. The contralateral striatum was injected with AAV1 DS-Red2 then 24 h later injected with AAV1-GFP at the same site. In both groups, approximately 75% of cells expressing GFP (direct fluores-Departments of Neuroscience and Molecular Genetics cence) also expressed DS-Red2 (fluorescent immunohistochemistry). and Microbiology, McKnight Brain Institute, Powell Gene However, the number of GFP-expressing cells far exceeded that of Therapy Center, Movement Disorders Center, University DS-Rred2 despite very similar titers. Therefore, an experiment where of Florida College of Medicine, Gainesville, FL, USA the same number of transducing units is injected in a mixed injectate is under way. In conclusion, these results suggest that two vectors We tested the hypothesis that overexpression of human parkin in cotransduce striatal neurons at a very high rate even with simple mixthe rat nigrostriatal system would be protective against progressive ing procedure and, therefore, injection of two separate rAAV vectors dopaminergic degeneration caused by intrastriatal 6-hydroxydopamine should be useful technique in a variety of gene transfer applications. Rat and Immunosuppressed Minipig ogy, it is possible that the neuropathology of idiopathic PD is caused by aggregation of proteins that is toxic to dopamine neurons. Thus, M. Marsala overexpression of parkin may be neuroprotective in animal models of PD by increasing the efficiency of clearance of damaged or misfolded Department of Anesthesiology, University of California, proteins. Using rAAV, it is possible to specifically overexpress human parkin in the rat nigrostriatal tract. Nine 8-week-old female Sprague-San Diego, CA, USA Dawley rats received two intranigral injections of 2 µl of rAAV5human parkin and nine rats received identical injections of rAAV-
In previous studies we have demonstrated that spinal grafting of human spinal neural precursors (hSCNPs) is effective in ameliorating green fluorescent protein as controls for viral transduction. Four weeks 336 ABSTRACTS functional deficits in rats with fully developed ischemic paraplegia.
with ischemic spasticity and rigidity. Human ES cells (H1; WiCell Res. Inst.) were used. During the nestin-positive stage the nestin-posi-One of the essential requirements that will define a successful translation of such therapies to a human patient with spinal ischemic injury tive rosettes were removed, infected with HIV1-Syn-EGFP (or Syn-DsRed) lentivirus, and then propagated in the presence of FGF-2 on is the characterization of a long-term survival/safety of such a spinally grafted cells as well as the definition of an optimal cell dosing regi-nonadherent surface. After 1-2 passages neuronal differentiation was induced by withdrawal of bFGF and addition of retinoic acid (1 µM) ment that will be reflective of neuroanatomical differences between rodents, large preclinical animal models, and humans. To systemati-for 5 days. A progressive appearance of green (or red) fluorescence in differentiating neurons was seen after 7-14 days. Fluorescent spheres cally address these issues we have recently completed a set of experiments to define: i) a long-term survival of spinally grafted hSCNPs were collected, dissociated using Pasteur pipette and filtered through 40-µm mesh. Spheres were then grafted into lumbar spinal cord in rats when grafted into the lumbar spinal cord of immunodeficient (ID) rats, and ii) the optimal dosing regiment of hSCNPs when grafted spinally with spinal ischemic injury. To induce spinal ischemia, in halothaneanesthetized rats the descending aorta was occluded for 10 min using in immunosuppressed naive minipig. In halothane-anesthetized ID rats hSCNPs were injected into lumbar gray matter using a 30-g needle a 2F balloon catheter and combined with systemic hypotension. After ischemia (before cell grafting) animals were allowed to survive for and Hamilton syringe. A total of 10 bilateral injections were made (30,000 cells/0.5 µl). After grafting, animals survived between 2 2-3 weeks. The final estimated cell density used for grafting was 5-10,000 cells/injection (0.5 µl). Cell injections were targeted into the weeks and 6 months, and were then perfusion fixed for quantitative and qualitative assessment of grafted cells. In isoflurane-anesthetized central gray matter between L2 and L5 segments. Total of 5-10 injections were made bilaterally. After grafting, animals survived for 2-4 minipigs (Minessota-Gotingen strain; 18-23 kg) a laminectomy of L2-3 vertebra was performed and animals received a total of 10 bilat-weeks and were then perfusion fixed with 4% paraformaldehyde. Transverse spinal cord sections were then prepared and stained with a eral injections of hSCNPs with incrementally increased density of injected cells (2,500-100,000/2-10 µl). After grafting, animals survived set of human-specific and nonspecific antibodies (including hMOC, hNSE, hSYN, NUMA, GFAP, and DCX) and analyzed with confocal for 6-7 weeks. In both studies changes in the open field motor behavior and sensory function were assessed periodically. In grafted ID rats microscopy. In grafted animals, numerous GFP-or dsRed-positive neurons with extensive processes were readily identified in grafted no detectable motor or sensory dysfunction was seen at any time postgrafting. Confocal analysis of spinal cord sections stained with human-segments. The majority of GFP-or dsRed-positive processes showed colocalization with DCX antibody (early neuronal marker) and with specific antibodies (NUMA, NSE, MOC) confirmed the presence of grafted cells in the central gray matter. In addition numerous NUMA-hMOC antibody. Staining with hSYN revealed an intense immunoreactivity, associated with DCX immunoreactive processes. Numerous positive cells in the white matter, presumably migrating from the injection site, were identified. In contrast to the early postgraftment DCX-positive processes were identified projecting from NUMA+ grafts towards persisting α-motoneurons. These data demonstrate that periods (i.e., 1-3 months) that were characterized by a prevalent expression of DCX immunoreactivity in grafted immature neurons, a ro-spinally grafted neural precursors derived from human blastocysts show similar survival and differentiation profile as seen after grafting bust NSE immunoreactivity and extensive axo-dendritic sprouting was seen in grafted neurons at 6 months after transplantation. Similarly, as of human spinal neural precursors or hNT neurons. While the therapeutic potency of these cells in modulating motor dysfunction after seen in ID rats, no detectable motor dysfunction or spinal pathology was seen in any grafted minipig. Postmortem MRI analysis of dis-spinal ischemia is not defined at present, these initial data demonstrate that hESC-derived NPs can represent an additional cell source for cell sected spinal cords confirmed the presence of individual injections within the gray matter of the L2-L4 segments. As previously seen in replacement therapy in patients with spinal ischemic injury. grafted rat spinal cords confocal analysis of grafted hSCNPs revealed an intense DCX immunoreactivity in NUMA-positive neurons at 6-7 weeks after grafting. In the majority of DCX-IR neurons the presence Effects of TNF-␣ and its Receptors on Fetal Ventral of human-specific synapatophysin immunoreactivity was also seen.
Mesencephalic Tissue Cultures Based on the stereological quantification of grafted cells and their spinal parenchymal distribution, the optimal density and volume of the F. Marschinke and I. Strömberg individual injection in the adult minipig spinal cord has been identified to be in the proximity of 30,000 cells delivered in 4-6 µl of vehicle.
Department of Integrative Medical Biology, Umeå University, Jointly these data demonstrate that the use of this cell line can repre-Umeå, Sweden sent an effective cell source used in cell replacement therapies in patients with spinal ischemic injury or other spinal pathologies characterized by a selective cell loss (such as multiple sclerosis or localized Neuroinflammation plays a critical role in aging as well as in many neurodegenerative diseases like Parkinson's disease (PD). cantly reduced when TNF-α was added at day 4 in vitro compared to the controls. Instead the glial-guided TH-positive outgrowth and the survival of such neuronal precursors after in vivo grafting in a variety of neurodegenerative models. In our previous studies we have shown astrocytic migration reached longer distances by treating cultures with TNF-α between days 4 and 7. TNF-α treatment between days 11 and a significant improvement in motor function after spinal grafting of human hNT neurons or human spinal neural precursors in rats with 14 triggered neither the TH-positive glial-guided outgrowth nor the astrocytic migration to reach longer distances at day 19. By adding spinal ischemic injury. The goal of the present study was to characterize the survival and differentiation profile of neuronal precursors gen-TNF-α together with the soluble antibody for TNF-α receptor 1 to the medium between days 4 and 7, the nonglial-guided TH-positive erated from human embryonic H1 cells when grafted spinally in rats outgrowth appeared again. Cultures were also stained with Ki67, Prenatal LPS Exposure Leads to Reduced Dopamine Process Extension: Proposed Mechanism for the Prenatal LPS Model which is expressed in all proliferating cells during G 1 , S, M, and G 2 phases of the cell cycle. The number of proliferating cells did not of Parkinson's Disease differ in the treated cultures compared to the controls. When counting the microglial cells using the pan-microglia marker Iba1 no differences A. J. Monahan, Z. Ling, N. Kannan, C. Zhao, B. Desai, were found when cultures were treated with TNF-α between days 4 and P. M. Carvey and 7 and taken at days 7 or 19, respectively. However, the number of microglia was significantly increased after TNF-α treatment be-Rush University, Chicago, IL, USA tween days 11 and 14 and evaluated at day 19. In conclusion, TNF-α is toxic for the nonglial dopaminergic nerve fiber outgrowth but stimu-
The cause of nonfamilial Parkinson's disease (PD) is currently unlates the glial-guided outgrowth as well the migration of astrocytes at known, although numerous neurotoxins have been implicated in studan early time point. TNF-α increased the number of microglia in VM ies that assume adult exposure. Our lab has shown that gravid female tissue cultures after late but not after early treatment.
rats exposed to the bacterotoxin lipopolysaccaharide (LPS) produce offspring with reduced numbers of dopamine (DA) neurons. These offspring have less striatal DA, an increase in DA activity, and an increase in proinflammatory cytokine release. The mechanism through Putative Mechanisms of Immune Tolerance of Human Retinal which LPS produces this effect is unknown. Using in vitro techniques,
Pigment Epithelial Cells (hRPEC) in CNS Xenotransplantation
we investigated here the effects of LPS on the early developmental stages of the nigrostriatal pathway. We tested the hypothesis that pre-N. I. Marupudi,* A. Harris,* M. M. Shankar,* A. M. Stull,* natal exposure to LPS attenuates the development of DA processes, P. Selvaraj, † T. Subramanian,* and K. Venkiteswaran* leading to underdevelopment of and loss of DA neurons in striatonigral cocultures. Female rats at E9.5 were injected with 100,000 endo-*Penn State University Hershey Medical Center, Hershey, PA, USA toxin units of LPS or 0.9% saline (SAL). At E14.5, all animals were †Emory University, Atlanta, GA, USA anesthetized with phenobarbitol followed by removal of the fetuses via c-section. The mesencephalic region containing the substantia nigra (SN) and lateral ganglionic eminence (striatum (ST)) were dis-Transplantation of hRPEC is an experimental therapeutic option sected from each fetus and pooled per animal. The tissues were dissofor patients with advanced Parkinson's disease (PD). To date, hRPEC ciated into a single cell suspension and plated as SN-ST cocultures. or hRPEC modified using recombinant lentiviral vector (rLV) to se-Fifty thousand ST cells were plated into a 96-well poly-lysine-coated crete GFP (hRPEC-rLV-GFP) have been safely xenotransplanted into tissue culture plate and allowed to adhere for 10 min at 37°C. Fifty parkinsonian rats and monkeys, and allotransplanted in PD patients to thousand SN cells were then cocultured with the ST cells according provide significant behavioral benefits in the absence of host immunoto the following treatment scheme: SAL-SN/SAL-ST; SAL-SN/LPSsuppression. hRPEC transplants do not show any evidence of cell pro-ST; LPS-SN/SAL-ST; LPS-SN/LPS-ST. The cocultures were then inliferation, migration, or neoplastic transformation when examined at cubated at 37°C for 7 days undisturbed, followed by fixation with 4% 3 months posttransplantation. There was minimal activation of host paraformaldehyde for 10 min and 0.01 M PBS rinses. The cells were microglia surrounding hRPEC grafts while FVM xenografts (positive stained with anti-tyrosine hydroxylase (THir) primary antibody and control) showed morphological evidence of graft rejection, MHC class counted per condition. The results demonstrated two overt effects. I (OX-18) and class II (OX-6) activation, and evidence of host micro-First, cocultures established from fetuses with prenatal exposure to glial activation (OX-42) in and around the rejecting FVM grafts. The LPS had less process extension morphologically. This was obvious in mechanisms that allow hRPEC xenotransplants to avoid a host imthe THir cells in the LPS-SN/SAL-ST condition and most obvious mune response in the brain are unknown. Malignant tumors are known in the LPS-SN/LPS-ST condition. The second effect appeared when to escape host T-cell-mediated immune response by not expressing assessing the number of DA cells per condition. The LPS-SN/LPS-ST costimulatory molecules like B7.1 that are obligatory to cause T-cell condition had significantly fewer cells compared to the SAL-SN/SALactivation, or by secreting proapoptotic immunomodulatory molecules ST and SAL-SN/LPS-ST conditions [F(3, 26) = 19.5, p < 0.001]. SN like FasL. We tested whether there were any similarities between varimonocultures established from LPS or saline prenatally exposed feous CNS tumors and hRPEC in their immune properties. Immunotuses exhibited decreased THir cell counts, with LPS prenatal exposure chemical staining failed to detect human B7.1 protein expression in revealing the most drastic effect when compared to control [F(5, 32) = hRPEC and hRPEC-rLV-GFP. Western blot analysis confirmed this 31.69, p < 0.001]. Given the reduced process extension and reduced finding. Jurkat T-cell leukemia, 9L and C6 gliomas also did not show cell counts observed in the LPS-SN/SAL-ST and LPS-SN/LPS-ST expression of B7.1 protein. In contrast, our positive control of CHO conditions, LPS may mediate its effect by altering striatal-derived trocells stably transfected with B7.1 showed robust immunocytochemical phic interactions with DA neurons. The reduction in DA neuron prostaining. Western blot analysis confirmed a 55-kDa band as expected cess extension would reduce access to target derived trophic factors, for human B7.1 and expression of a soluble form of FasL in hRPEC leading to DA cell death. LPS exposure may also reduce DA autotroand hRPEC-rLV-GFP culture supernatant with an expected molecular phic factors. This mechanism is consistent with our observation that weight of 25. Densitometric analysis shows FasL expression levels to adult animals exposed to LPS prenatally have significantly fewer DA be similar to levels found in glioma cell lines. These results taken cells. together suggest that putative mechanism through which hRPEC and Supported by DOD and the Richard Nopar Foundation. hRPEC-rLV-GFP xenografts potentially escape host T-cell-mediated immune attack is by not expressing costimulatory molecules (e.g., B7.1), resulting in inadequate T-cell costimulation and active suppression of any potential host immune response by secreting a soluble Neurotrophic Changes Mark the Onset of Preclinical form of FasL that is known to be proapoptotic to activated T cells.
Alzheimer's Disease: Therapeutic Implications Further, our results also demonstrate that rLV-mediated stable GFP transfection does not alter the immune properties of hRPEC. Under-E. J. Mufson,* S. E. Counts,* and S. Ginsberg † standing the mechanisms through which hRPEC escape host immune detection may provide useful insights that allow us to devise new tech-*Department of Neurological Science, Rush University Medical niques to enhance the survival of other CNS cell transplants including Center, Chicago, IL, USA stem cell transplants in PD and other neurodegenerative disorders.
†Nathan Klein Institute, NYU Medical Center, New York, NY, USA This research was funded in part by NIH/NINDS R01 NS42402, Pennsylvania TSF grant, HRSA Physician Scientist Award DIBTH 06321 to T.S., Medical Student Research Award from PDF to N.I.M., The cholinobasal cortical projection system requires nerve growth factor (NGF) for its biological activity and is selectively vulnerable and Penn State SURIP award to A.H.
in advanced Alzheimer's disease (AD). The molecular mechanisms hydrogenase activity demonstrated that 2-APB reduced proliferation in a dose-dependent manner that could be partially to completely re-underlying the vulnerability of cholinergic basal forebrain (CBF) neurons within the nucleus basalis (NB) during the preclinical stage of versed with the application of ATPγS. These results suggest that VIPP expression and 2-APB reduce proliferation, in a reversible manner, by AD remain unknown. To determine whether the pathological alterations seen in this system in advanced AD occur early in the progres-attenuating IP 3 -mediated signaling and calcium signaling. Neurosphere assays demonstrated that transfection of NSCs with either EGFP or sion of the disease we investigated changes in the cholinotropic CBF system using postmortem tissue from subjects clinically categorized VIPP resulted in a 25% reduction in the number of neurospheres compared to nontransfected controls. Although the numbers of neurosph-with no cognitive impairment (NCI), mild cognitive impairment (MCI), or AD. Surprisingly, the number of chloline acetyltransferase eres were similar in EGFP-and VIPP-transfected NSCs, EGFP-transfected neurospheres were significantly larger than VIPP-transfected (ChAT)-positive neurons was unchanged in MCI and mild AD, while the number of neurons immunopositive for the NGF receptors trkA NSCs. These results suggest that VIPP expression leads to an attenuation of proliferation and therefore may promote differentiation. Immu-and p75NTR was significantly reduced compared to NCI, supporting the concept of a phenotypic alteration rather than frank CBF neuronal nocytochemistry and electrophysiological approaches are being used to assess functional changes in NSCs. To determine if inhibition of degeneration in MCI. Gene expression profile analysis of single cholinergic neurons revealed that trkA mRNA was decreased in MCI and IP 3 signaling promotes enhanced survival of transplanted NSCs, we are using NSCs with intact or attenuated IP 3 signaling by in vivo 2-correlated with cognitive decline, suggesting that decreased neurotrophin responsiveness is an early biomarker for AD. Although NGF photon imaging to repeatedly examine engraftment and migration in a control and mouse model of cortical neuronal death. We will examine mRNA levels remain stable in AD, cortical proNGF is increased in MCI and AD cortex, suggesting that proNGF accumulates due to re-functional integration by using in vivo Ca 2+ imaging and fluorescenceguided whole-cell patch clamp recordings to determine the effects of ductions in trkA in prodromal AD. The fact that cholinergic neuron number and cortical ChAT activity are not altered in MCI suggests attenuated IP 3 signaling on the expression of ionic currents in transplanted NSCs. We will also use a novel real-time PCR method coupled that compensatory mechanisms occur in the remaining cholinergic perikarya that normalize cortical ChAT levels. Reductions in trkA may with confocal stereology to determine whether attenuation of IP 3 signaling promotes survival and differentiation after transplantation. By be an early sign of a trafficking defect in CBF neurons leading to reduced NGF utilization. Ultimately, there is an accumulation of focusing our experiments on the critical second messenger, IP 3 , we have the opportunity to identify an important signal that will both have proNGF in CBF target sites, and a lack of retrograde NGF signals crucial for gene transcription mediating cell survival may be mani-pleiotropic actions on NSCs and offer benefits for transplantation strategies. It will be possible not only to differentiate cells but also to fested by cognitive impairment during the progression of AD. Single cell profiling also revealed no significant differences in expression lev-enhance their survival after transplantation. els for the six tau isoforms across groups within CBF neurons. However, a significant decrease in the 3Rtau/4Rtau expression ratio was Progenitor Cells of the Ventral Mesencephalon Increase found in MCI and AD relative to NCI, suggesting that neurotrophic in Response to Prenatal Lipopolysaccharide (LPS) Exposure changes may play a role in the development of neurofibrillary tangles While Dopamine Neurons Decrease in CBF neurons. Taken together, these cholinotrophic CBF molecular studies suggest that people with MCI are already in the early stages of AD. A recent phase I clinical trial of NGF intraparenchymal gene M. B. Newman,* † ‡ C. Zhao,* R. A. E. Bakay, ‡ therapy directed at the CBF for the treatment of mild AD has shown and P. M. Carvey* † promising results with no adverse affects and indicates that this treatment may even slow the course of the disease. Parkinson's disease (PD) have assumed exposure to toxin during adult life. In contrast, studies from our laboratory suggest that prenatal exposure may be just as important. We have shown that treating gravid Neural stem cells (NSCs) have demonstrated the ability to provide both neural replacement and neuroprotection leading to increased female rats with the bacteriotoxin lipopolysaccharide (LPS) produces offspring born with fewer dopamine (DA) neurons, and this reduction functional recovery following transplantation in several animal models of neurological disorders. Though several factors have been observed persists throughout adulthood, progressing with age. Unfortunately, the mechanisms responsible for the LPS-induced changes in the DA to induce proliferation and differentiation of NSCs in vitro, cell survival posttransplantation is limited. We are currently testing the hy-system are unknown. Our preliminary in vivo study using bromodeoxyuridine (BrdU: a nucleotide substitution that replaces thymidine with pothesis that IP 3 signaling regulates NSC proliferation, differentiation, survival, and function in vitro and in vivo. We are using several strate-uridine in the DNA structure of dividing cells) suggests that LPS may reduce the mitotic activity of DA progenitor cells in the ventricular gies to examine IP 3 -mediated regulation of NSC fate including membrane-permeant IP 3 analogs, pharmacological inhibition of the IP 3 re-area of the mesencephalon, which could lead to reduced migration of DA progenitors to the nigra. We have since completed the study that ceptor, and overexpression of IP 3 5-phosphatase and of the IP 3 binding portion of the receptor. We have recently generated a lentiviral system evaluated this possibility. Gravid rats at E10.5 were injected (IP) with either 10,000 EU of LPS or saline. Both treatment groups were then to overexpress venus-tagged IP 3 5-phosphatase (VIPP), which metabolizes IP 3 , for the purpose of examining IP 3 -mediated regulation of Ca 2+ administered 70 mg/kg of BrdU (IP) 2 h later at E11.5 and again at E12 and E12.5. On E18, gravid rats were anesthetized with pentobar-signaling through the attenuation of IP 3 signaling compared to EGFPtransfected (viral control) and nontransfected NSCs. Preliminary data bital (60 mg/kg), the fetuses were removed, and the whole brain of the fetuses were quickly removed and processed for storage. Brains using assays to determine BrdU incorporation, cell proliferation, neurosphere colony formation, and apoptosis indicate that both VIPP ex-were then sectioned at 60 µm on a horizontal plane and processed for immunohistochemistry. Only one fetus brain from each gravid rat was pression and pharmacological inhibition of the IP 3 receptor attenuate proliferation and promote differentiation without promoting cell death.
used for each dependent measure. The entire sectioned brains were processed for tyrosine hydroxylase (TH, a DA neuron marker), BrdU, VIPP expressing NSCs had an 80% reduction in BrdU incorporation compared to nontransfected controls and a 50% reduction compared or THir/BrdU (double-labeled) immunolabeling. The estimation of the total number of cells throughout the entire brain was performed using to EGFP controls. Cell proliferation as measured by mitochondrial de-stereological techniques. Immunohistochemistry revealed two distinct †Section of Immunobiology, Yale University School of Medicine pathways from which DA progenitors (TH/BrdU-labeled cells) miand Howard Hughes Medical Institute, New Haven, CT, USA grate, the median stream cells and the ventrolateral stream. The cell ‡Institute of Laboratory Animal Science, Saitama Medical Center/ counts for BrdU-labeled cells showed no significant differences be-School, Kawagoe, Saitama, Japan tween LPS and the saline condition except in the ventral mesencepha- §Center for Excellence in Aging and Brain Repair, Department lon (VM) area, in which there were more BrdU-labeled cells in the of Neurosurgery, College of Medicine, University of South Florida, LPS condition brains than in the saline brains, whereas the THir cell Tampa, FL, USA counts from the LPS condition showed a 32-40% reduction compared ¶Saneron CCEL Therapeutics, Inc., Tampa, FL, USA to the same brain areas in saline control condition. The substantia nigra (SN) and the more ventral area of the SN exhibited significantly fewer TH cells compared to their saline condition counterpart. Interestingly, Alzheimer's disease (AD) is the most common progressive dethere were significantly more BrdU/THir-positive cells from fetuses menting disorder, and is characterized by deposition of the 40-42 exposed to LPS than those exposed to saline. The substantia nigra had amino acid amyloid-B-peptide (AB), as B-amyloid in senile plaques. the highest number of double-labeled cells, followed by a more ventral A previous study showed that infusion of Saneron's proprietary fracarea of SN, and then by the VM area around the LC and 4th ventricle.
tion (U-CORD-CELL TM ) of human umbilical cord blood cells The BrdU/THir-positive cells were also present in control brains, indi-(HUCBC) significantly extends the life of transgenic mice overprocating normal progression of DA neurons. These results suggest a ducing AB. Here, we report that HUCBC-infused mice doubly transcompensatory role in the progenitor cells that must recognize a defect genic (PSAPP) for mutations in human amyloid precursor protein and in TH cell production consequently from the LPS prenatal exposure.
presenilin-1 (APPswe, PSEN1dE9) showed decreased astrocytosis and Thus, the results indicate that prenatal LPS exposure does not interfere microgliosis associated with diminished AB plaque load. Furthermore, with the progenitor cell production in producing DA neurons. these mice also showed increased anti-inflammatory T helper (Th) lymphocyte type 2 (Th2) associated cytokines interleukin ( Striatal medium spiny neurons (MSNs) are the major target neurent induction of autoimmune meningoencephalitis or other detrimental rons for nigral dopamine (DA) and cortical glutamate projections. As side effects are lacking. To address this issue, we implemented Ab their name implies, these MSNs contain numerous dendritic spines, transcutaneous (t.c.) vaccine strategies. Often a well-tolerated treatknob-like extensions on the surface of the dendrites, onto which dopament strategy for numerous diseases, t.c. immunization offers unique mine and glutamate inputs converge in an ordered and specific pattern. immunomodulatory potential. In this study, Ab1-42 t.c. immunization
In advanced Parkinson's disease (PD) there is marked atrophy of denof C57BL/6 mice with cholera toxin (CT) resulted in high anti-Ab dritic spines on MSNs (e.g., McNeill et al., Brain Res., 1988) , with antibody titers (mainly IgG1) and splenocyte immune responses after similar pathology observed in mice and rats with severe DA depletion rechallenge with Ab1-42 peptide. Furthermore, to evaluate the effect (Day et al., Nat. Neurosci., 2006) . It has recently been demonstrated of t.c. immunization on reducing b-amyloid associated pathology, we that dysregulation of intraspine L-type Ca 2+ channels contributes to t.c. immunized transgenic PSAPP (APPsw, PSEN1dE9) mice with agspine loss following striatal DA depletion. Indeed, administration of gregated Ab1-42 peptide in combination with CT. These mice showed the calcium channel antagonist nimodipine to rats, or absence of these high anti-Ab antibody titers, significant decreases in cerebral Ab1-40, channels in transgenic mice, prevents dendritic spine loss despite se-42 levels with increased circulating levels of Ab1-40, 42 and resultant vere DA depletion. Within this context of striatal DA depletion and cerebral b-amyloid plaque reduction when compared to PSAPP mice spine loss, the standard therapy for PD is administration of levodopa. given CT alone. These data suggest that t.c. immunization may be a With chronic administration of levodopa a significant portion of PD novel, effective, and safe treatment strategy for AD. ). The precise mechanism by which DA depletion influences glu-J. Zeng,* R. D. Shytle,* § C. Davis Sanberg, ¶ P. R. Sanberg, § tamate-dependent synaptic plasticity, and the degree to which alterand J. Tan* § ations in glutamate-dependent synaptic adaptations secondary to spine loss contribute to LID development remains unclear. However, it is *Neuroimmunology Laboratory and Department of Psychiatry clear that severity of presynaptic DA denervation plays an important and Behavioral Medicine, University of South Florida, role in the development of LIDs (e.g., Fahn, Ann. Neurol., 2000) . To examine whether spine loss plays an important role in development of Tampa, FL, USA 340 ABSTRACTS levodopa-induced abnormal movements, we have been comparing lev-lase-immunoreactive and mNP cells within each group. Coronal sections will be processed and analyzed for neurotrophic factor, antiapo-els of dyskinetic behaviors in severely DA depleted rats treated with nimodipine to prevent spine loss to non-nimodipine, vehicle control-ptotic factor, and anti-inflammatory cytokine levels to determine mechanisms involved in mNP cell-induced protection. Although pre-treated animals, which experience dendritic spine loss. Animals were implanted with continuous release nimodipine pellets or vehicle pellets liminary, these findings indicate a cografting paradigm may be an effective strategy to increase grafted DA neuron survival and/or func-at the time of 6-OHDA nigral lesions. Two weeks after the lesion, a time when spine loss occurs in non-nimodipine animals, daily levo-tion.
Supported by University of Cincinnati Millennium Fund (T.J.C.) . dopa injections were initiated (12.5 mg/kg levodopa: 12.5 mg/kg benserazide; IP). In addition to daily monitoring of dyskinetic behaviors, we have been employing a forepaw step adjusting task to monitor the impact of spine loss on parkinsonian motor impairment.
Step adjusting Early Selection of Ventral Midline Progenitors performance was measured prior to and after lesioning in all treatment From Human Embryonic Stem Cells to Increase groups. Results of detailed behavior and morphology of MSNs will be the Production of Dopamine Neurons presented.
This work is supported by the Millennium Scholars Fund human and primate ES cells by expression of regional (midbrain) and Cincinnati, OH, USA cell-specific transcription factors as well as by conserved axonal targeting (Ferrari et al., 2006) . However, the inductive differentiation Parkinson's disease (PD) is characterized by the degeneration of protocol is not sufficient to obtain pure dopamine neuronal populadopamine (DA) neurons in the substantia nigra (SN), resulting in lost tions. Selection approaches at late stages of ES differentiation may striatal DA. One therapeutic approach to restore DA tone is grafting result in pure populations but may also significantly reduce the yield, fetal ventral mesencephalic (VM) cells into the denervated striatum. so we looked for early markers of presumptive dopamine progenitors. This approach has been demonstrated to be successful in open label Dopamine neurons are derived from or specified by floor plate cells trials, but the limited availability of embryonic donor tissue, poor sur- (Hynes et al., 1995) , which are neuroepithelial cells that occupy the vival of grafted cells, and dyskinetic side effects after grafting have ventral midline and express sonic hedgehog, netrin-1, and FOXA2 hindered the widespread use of this therapy. In the present study, we (Ruiz i Altaba, 1993; Placzek and Briscoe, 2005) . Ectopic expression hypothesize that undifferentiated midbrain neural progenitor (mNP) of FOXA2 is accompanied by the generation of an ectopic cluster of cells can protect transplanted embryonic DA neurons when simultanedopamine neurons (Hynes et al., 1995) . Here, we aimed to use the ously cografted to the striatum in the PD rat model. Previously, we FOXA2 promoter to drive a reporter gene to select this floor plate confirmed the ability of undifferentiated mNP cells to protect endogeprogenitor population from other ES derived neuroepithelial cells. We nous nigral DA neurons in vivo when grafted adjacent to the SN in have confirmed expression of FOXA2 in hES cells at the rosette stage the 6-hydroxydopmine (6-OHDA) model of PD. Additionally, in vitro by immunocytochemistry. Based on preliminary experiments, showing coculture data indicate that one mechanism of mNP cell-derived neulow survival of hES cells FAC sorted at the neuroepithelial (rosette) roprotection is the secretion of trophic factors. Collectively, these findstage, we decided to use antibiotic resistance for selection at this time. ings indicate that cografting undifferentiated mNP cells with primary
We have made two constructs with the puromycin resistance gene VM cells may prove to be an effective strategy for increasing grafted driven by the FOXA2 promoter sequence and cloned them into lentivifetal DA neuron survival and function. This effect may be mediated ral vectors. We have established functionality of both constructs in by the ability of mNP cells to provide a continuous supply of neurohuman hepatocyte HepG2 cells, which constitutively express high levtrophic support during the immediate postgrafting interval when most els of FOXA2. Selection of human ES cells and phenotypic charactergrafted cell death occurs. We utilized transgenic rats carrying the huization of the selected population after expansion and subsequent difman placental alkaline phosphatase transgene (hPAP) under the conferentiation are under way. We expect to demonstrate that this selection trol of the ROSA26 promoter to identify and characterize the mNP strategy can increase the yield and purity of the dopamine cell populacells after transplantation. mNP cells were derived from embryonic tion at the end of the differentiation protocol. day 14 (E14) hPAP Fischer 344 rats, dissociated, and cultured in mitogen-supplemented medium for 3 weeks. Primary VM tissue was dissected and dissociated from wild-type E14 Fischer 344 rats on the day Penumbral Neuropreservation Mediated by Decreased Caspase-9 of surgery. All groups received two injections placed into the dener-Activation With an EPO Derivative vated striatum separated by a distance of 1 mm 3 weeks after a unilateral 6-OHDA lesion. Fischer 344 host rats received one of the follow-C. Price, R. Chaparro, S. Chalavarya, D. Coppola, ing treatments: 100,000 embryonic VM cells (1 µl) adjacent to vehicle and E. Camporesi (1 µl), 50,000 undifferentiated mNP cells (1 µl) adjacent to vehicle (1 µl), 50,000 embryonic VM cells (1 µl) adjacent to vehicle (1 µl), Anesthesiology, University of South Florida, Tampa, FL, USA 50,000 undifferentiated mNP cells (1 µl) adjacent to 50,000 embryonic VM cells (1 µl), two injections of vehicle only. Rotational behavior was assessed following amphetamine challenge at 2, 4, 6, 8, and 12 Apoptosis is the delayed process of programmed cell death, consisting of well-defined differences compared to the acute development weeks postgraft. Of the animals receiving 50,000 grafted VM cells, only those in the mNP cograft group exhibited significant amelioration of necrosis, and occurs in the region surrounding the initial necrotic injury after an ischemic stroke. Apoptosis involves the activation of of rotational asymmetry. Furthermore, behavioral effects in the 50,000 VM cell cograft animals were equivalent to that provided by the caspases, cysteine proteases that remain inactively present in all cells until cleaved. During neuronal ischemia, caspase-9 is released from 100,000 VM cell grafted animals. Stereological studies are under way to determine the number of surviving transplanted tyrosine hydroxy-the mitochondria through a compromised mitochondrial membrane.
Erythropoietin (EPO) has demonstrated antiapoptotic properties both age-related neurodegeneration. In summary, we measured glutamate signals on a second-by-second basis in the nonhuman primate cortex in vitro and in vivo in models of ischemia by the preservation of the mitochondrial membrane. The aim of this study was to determine the and established a foundation for translating this technique to a clinical setting. effect of nonerythropoietic asialoerythropoietin (a-EPO) on apoptoticspecific cell death after ischemic brain injury. Sprague-Dawley rats Support provided by USPHS AG00242, NS39787, AG013494, DA017186; NSF DBI 0352848. were monitored for 4 days following 90 min of reversible middle cerebral artery occlusion (MCAO) and subcutaneous implantation of an osmotic minipump (control = saline, experimental = a-EPO, 20 µg/kg per day). On day 4, saline perfused brains were fixed in 10% formalin Gene Therapy Using AAV-Neurturin (CERE-120) and immunohistochemically stained for active cleaved caspase-9. The in a Transgenic Mouse Model of Huntington's Disease saline control group (n = 9) demonstrated active caspase-9 positive results in an average of 24.6% of the total brain field, compared with S. Ramaswamy,* J. L. McBride,* L. Zhou,* E. Berry-Kravis,* the a-EPO group (n = 9), which demonstrated active caspase-9-posi-C. D. Herzog, † M. Gasmi, † R. T. Bartus, † and J. H. Kordower* tive results in an average of 6.6% of the total brain field (p < 0.001). Although a-EPO may be capable of reducing the amount of activated *Department Neurological Sciences, Rush University Medical cleaved caspase-9 and apoptosis after ischemic brain injury, whether Center, Chicago, IL, USA a-EPO maintains the mitochondrial membrane as EPO has previously †Ceregene Inc., San Diego, CA, USA shown to do, or whether a-EPO blocks the binding and activation site of caspase-9 is still unclear.
Huntington's disease (HD) is an inherited neurodegenerative disorder that currently has no effective treatment. Our group has previously shown that AAV-Neurturin (NTN) gene therapy is neuroprotective and week for the duration of the study. All animals were sacrificed at age of Excellence, University of Kentucky, Lexington, KY, USA week 16. Average weekly rotorod scores were compared between ‡Center for Microelectrode Technology, University of Kentucky, groups. At week 11, GFP-Tg and Veh-Tg mice showed similar and significant declines on the rotorod, compared to Veh-Wt mice (p < Lexington, KY, USA 0.05). In contrast, NTN-Tg mice began to decline on the rotorod at week 14 (p < 0.05) and performed significantly better than GFP-Tg Glutamate is the principle excitatory neurotransmitter of the central nervous system and is essential for normal neural function. Alterations and Veh-Tg mice between weeks 11 and 16. Total number of clasping events over the duration of the study was summed for each animal and in the glutamatergic system are associated with a host of neurodegenerative diseases as well as altered neural function during aging; how-averages were compared between groups. GFP-Tg and Veh-Tg animals had significantly more clasping events than Veh-Wt animals ever, relatively little is known about glutamate signaling in the primate brain. One limitation has been the availability of an in vivo method (p < 0.05). In contrast, the total number of clasping events for the NTN-Tg group was similar to that of the Veh-Wt group. Coronal sec-capable of measuring the rapid dynamics of glutamate neurotransmission and potentially available in the clinic. We have addressed this tions were analyzed for the neuronal marker NeuN and mutant huntingtin positive inclusions. Stereological counts of NeuN-labeled cells paucity of information by measuring extracellular glutamate at a second-by-second rate in the neocortex of anesthetized rhesus monkeys in the striatum revealed a 49.6% neuronal loss in the GFP-Tg group and a 39.5% loss in the Veh-Tg group. This was a significant reduction using a recently developed enzyme-based microelectrode technique. We applied constant potential amperometry (+0.7 V vs. Ag/AgCl) to from the number of cells in both the NTN-Tg group and the Veh-Wt group (p < 0.05). In contrast, the NTN-Tg group only showed a 6.4% glutamate-oxidase-coated microelectrodes to measure both tonic and phasic glutamate release. Measures were carried out at multiple depths cell loss. Cell volume analysis was conducted on NeuN-labeled cells in the striatum to evaluate cell atrophy. All transgenic groups showed from −1.0 mm down to −3.0 mm below the brain surface in the premotor and motor cortices of young, middle-aged, and aged animals (n = a significant and similar reduction in striatal cell volume compared to the Veh-Wt group (p < 0.001), indicating that AAV-NTN did not res-4 each). In the motor cortex, mean resting glutamate levels were five times higher in aged monkeys compared to young monkeys (20.3 ± cue this volume deficit. Mutant huntingtin (mHtt) inclusions are a pathological hallmark of HD and are seen in striatal cells in this trans-7.9 µM, n = 9 signal measurements vs. 3.7 ± 0.9 µM, n = 13; p < 0.05, respectively) and middle-aged monkeys (8.8 ± 2.3 µM, n = 18; not sig-genic mouse model. Total percentage of striatal neurons containing mHtt inclusions was compared between groups. All transgenic groups nificantly different). Meanwhile, in the premotor cortex, the average resting glutamate levels in aged monkeys were 8.9 ± 2.1 µM versus displayed a similar percentage of striatal neurons containing inclusions (p = 0.925). These results indicate that AAV-NTN gene therapy may 3.8 ± 1.7 µM in young and 6.7 ± 1.1 µM in middle-aged monkeys (not significantly different) (n = 13 ,17, 11, respectively) . In addition, we provide relief from motor deficits and striatal cell death in HD. measured rapid, phasic glutamate release lasting a few seconds after local, pressure-ejection delivery of nanoliter volumes of either isotonic 70 mM potassium (to stimulate glutamate release) or 1 mM glutamate Blueberry-Enriched Diet Regulates Tenascin Levels (to study glutamate uptake). In the motor cortex, we measured reproin Dopamine-Depleted Striatum ducible glutamate signals that had rates of glutamate uptake that decreased by 47% in aged animals compared to young animals (2.1 ± A. Rehnmark,* C. Gemma, † P. C. Bickford, † and I. Ströberg* 0.3 µM/s vs. 4.0 ± 0.6 µM/s, p < 0.05; n = 11 and 12, respectively; middle aged: 3.8 ± 0.5, n = 11, p > 0.05). However, following 70 mM *Department of Integrative Medical Biology, Umeå University, potassium delivery, we did not observe any consistent changes in Sweden young versus aged animals. Our results support the hypothesis that the †Department of Neurosurgery, University of South Florida, glutamate system undergoes changes during the aging of the central nervous system, and these changes may be associated in part with Tampa, FL, USA 342 ABSTRACTS Diets enriched in antoxidants have been shown to modulate the random combinations. Rats were euthanized at 4 days, 7 days, 14 days, 28 days, and 9 months postvector injection; one series of sections was neuroinflammation after injury of the rat nigrostriatal dopamine system. An increased microglia response seen 1 week after striatal 6-mounted for visualization with epifluorescence and one series was stained with an anti-GFP antibody. Transduced cell number was esti-OHDA injections in animals fed with diet enriched in antioxidants is followed by significantly decreased microglia response 4 weeks after mated by unbiased stereological sampling methods from the stained series of sections. When examining the native fluorescence, there was the lesion, while in control animals the microglia reaction increased over time. This early microglia response seems to be associated with little or no detectable gene expression prior to 2 weeks posttransduction for any pseudotype. However, when stained sections were evalu-regeneration of dopamine terminals at the border of the lesioned area towards center portions of the lesion as observed 4 weeks after the ated, significant gene expression was detected at all time points including 4 days. Moreover, retrograde transport to the substantia nigra was lesion in animals fed with blueberry. Interestingly, dopamine nerve fiber density is reduced after the dopamine lesion in the globus pal-detectable by 7 days postvector injection. rAAV2/8 vectors displayed the most efficient striatal transduction and the greatest retrograde lidus, and blueberry diet could not improve regeneration in this area. This study aims at measuring the levels of factors involved in the transport to the substantia nigra. These data indicate that low levels of rAAV-mediated protein expression commences rapidly after transduc-regenerative process after dopamine degeneration [e.g., the levels of the nerve growth factor glial cell line-derived neurotrophic factor tion and these levels increase at least for 28 days postvector injection. (GDNF) and extracellular matrix molecules such as tenascin-C]. Tenascin-C is a glycoprotein known to exert effects on neurite formation Oral Administration of Green Tea Epigallocatechin-3-Gallate and is widely expressed in the brain during early development but is (EGCG) to a Mouse Model of Alzheimer's Disease Reduces downregulated during maturation but remains at high levels in areas Beta-Amyloid Burden and Modulates Tau Pathology of active neurogenesis. GDNF and tenascin-C levels in the striatum and the globus pallidus have been measured using enzyme-linked im-K. Rezai-Zadeh,* D. Shytle,* † G. Arendash, ‡ N. Sun,* H. Hou,* munosorbent assay (ELISA) and immunohistochemistry. According to J. Zeng,* T. Mori,* D. Morgan, § and J. Tan* † § ELISA measurements, the GDNF levels were higher in lesioned striatum compared to the control side in both animals fed with control diet *Neuroimmunology Laboratory, Silver Child Development Center, and blueberry-enriched diet. In the globus pallidus, the GDNF levels were similar in the lesioned sides of all animals and were higher over-Institute for Research in Psychiatry, Department of Psychiatry all compared to striatal levels. In control animals, tenascin immunore-& Behavioral Medicine, University of South Florida, activity revealed weak fluorescence 1 week after striatal 6-OHDA in-Tampa, FL, USA jection, while increased intensity was seen after 4 weeks. Tenascin †Center for Excellence in Aging and Brain Repair, Department immunoreactivity was below detection limit in sham-operated control of Neurosurgery, University of South Florida, Tampa, FL, USA animals as well as in the globus pallidus. In conclusion, although dopa- ‡The Byrd Alzheimers Center and Research Institute, mine regeneration occurs in the striatum but not in the globus pallidus Tampa, FL, USA of animals fed with blueberry diet, the GDNF levels were higher in the §Department of Molecular Pharmacology & Physiology, University globus pallidus compared to striatal levels. However, the presence of of South Florida, Tampa, FL, USA tenascin corresponded well with dopamine regeneration because high tenascin intensity was present in animals showing regeneration.
Alzheimer's disease (AD) is a progressive neurodegenerative disorder pathologically characterized by deposition of beta-amyloid (Abeta) peptides as senile plaques in the brain. Previous studies sug-
Quantitative Study of Onset of Striatal Transgene Expression
gest that green tea polyphenols may be used for the prevention and of Different rAAV Serotypes treatment of a variety of neurodegenerative diseases. Recently, we reported that intraperitoneal injection of (−)-epigallocatechin-3-gallate (EGCG), the main polyphenolic constituent of green tea, decreased S. K. Reimsnider,* ‡ § F. Manfredsson,* ‡ § C. Burger, † ‡ § Abeta levels and plaques via promotion of the trophic nonamyloidoge-N. Muzyczka, † ‡ § and R. J. Mandel* † ‡ nic alpha-secretase proteolytic pathway in "Swedish" mutant amyloid precursor protein (APP)-overexpressing mice (Tg2576 (J.T. and D.S.) . serotypes with expression cassettes driven by specific promoters, flanked with the AAV2 terminal repeats that show different tropisms and increased transduction efficiency in specific brain areas. rAAV2-Development and Preclinical Safety Validation of a Stabilized based vectors have been reported to begin expressing protein after a Intraspinal Microinjection Platform delay but this has not been well characterized in the CNS. The purpose of this study was to characterize the onset of expression of four pseu-J. Riley,* J. Park, † J. Butler, † and N. Boulis* dotypes of the AAV vector. Capsids of AAV1, AAV2, AAV5, and AAV8 containing a green fluorescent protein expression cassette under *Department of Neurosciences and Center for Neurological the control of the CBA promoter, flanked by the AAV2 terminal re-Restoration, Cleveland Clinic, Cleveland, OH, USA peats, were constructed to produce the pseudotypes rAAV2/1, rAAV2/ †Department of Neurosurgery, Cleveland Clinic, 2, rAAV2/5, and rAAV2/8. Rats were given an intrastriatal injection of these vectors, with both striatum injected with a different vector, in Cleveland, OH, USA
The development of cell-and viral-based molecular therapeutics Molecular and Behavioral Characterization of a Knock-In Mouse Model of Huntington's Disease represents promising avenues of research in the attempt to achieve neuroprotection or neurorestoration throughout the neuraxis. Though a variety of delivery strategies are currently being researched, none A. Rising,* A. S. Lewin,* E. M. Denovan-Wright, † has yet been validated for introduction of molecular therapeutics to and R. J. Mandel* the spinal cord. To address this unmet need, we have developed a spinal cord microinjection platform and have generated initial target-*Department of Neuroscience, University of Florida, ing and behavioral validation data regarding the utility of this approach Gainesville, FL, USA for delivery of both cellular and viral therapeutics to the lumbar and †Department of Pharmacology, Dalhousie University, cervical spinal cord.
Halifax, Canada Two prototype stabilized microinjection platforms have been constructed in the Biomedical Engineering Prototype Lab, specialized for Huntington's disease (HD) is a neurological disease that is caused attachment to the lumbar and cervical cord. The lumbar microinjection by an expanded poly-glutamine region in the protein Huntingtin. The platform is designed to span a two-level lumbar laminectomy, attachdisease is characterized by uncontrollable jerky movements called choing at the adjacent spinous processes L2 & L5. The cervical platform rea, dementia, and personality changes. Various mouse models have is designed to span a one-to two-level cervical laminectomy, attaching been developed to study the progression of HD. In this study, we exrostrally to the occipital crest and caudally to the spinous process of amine the behavioral and histopathological characteristics of a knock-C7. Seven pigs (30-40 kg, female) have undergone physiologic mapin mouse referred to as pQ140. The pQ140 mouse model show a tranping (microelectrode recording) and cell-based microinjection into the scriptional downregulation of mRNAs that have in the past been lumbar spinal cord. Six pigs (30-40 kg, female) have undergone cervishown to be downregulated in postmortem HD brains. The downregucal microinjection under guidance of coordinate-based microinjection, lated transcripts examined here were preproenkephalin (ppENK), dothree each with either cellular or viral payload. All pigs have underpamine-and cAMP-responsive phosphoprotein 32 kDa (DARPP-32), gone baseline and postoperative behavioral motor and sensory testing.
dopamine receptor type 2 (D2), phosphodiesterase 1b (PDE1b), Following sacrifice, the injected spinal cord segment and adjacent con-PDE10A, dynamin, nerve growth factor-inducible A (NGFi-A), and trols were removed and processed for histologic analysis.
cannabinoid receptors (CB1). Neuronal intranuclear inclusion bodies The initial series of seven microinjection procedures was per-(NIIS) are also evident and increase over time as the pQ140 phenotype formed in the lumbar cord. All animals were sacrificed acutely, after progresses. In addition to decreases in mRNA levels and the presence postoperative assessment at t = 3 h. Histologic analysis supported our of NIIs, the pQ140 mice show a decrease in activity when placed in a ability to achieve localization to the ventral horn in the spinal cord.
clear cylinder and a deficit in motor skills. Behavioral tasks such as The cell graft localized to the ipsilateral cord in the area surrounding rearing and latency to fall off a rotorod, at both accelerating and conthe injection site and was not evident in the contralateral horn or in stant speed, show significant differences between heterozygous and adjacent controls. Complications included death (n = 1), an epidural homozygous mice and their wild-type litter mates. The histopathology hematoma (n = 1), and hindlimb dysfunction (n = 3). The mortality, and behavior differences observed in the pQ140 knock-in mice will occurring during closure, was attributed to the development of maligbe invaluable to the study of HD and when assessing the therapeutic nant hyperthermia following intraoperative administration of an effects of treatments for HD. NSAID. Malignant hyperthermia has an incidence of up to 12% in this animal model. One instance of hindlimb dysfunction was attributable to the development of an epidural hematoma over the laminectomy site. The remaining occurrences (n = 2) of hindlimb dysfunction were
The Phrenic Motor Circuitry After Cervical Spinal Cord Injury: attributable to either microelectrode recording or infusion. In an at-Insights From Neurophysiological Methods tempt to reduce morbidity, subsequent microinjection procedures in the cervical cord were performed with coordinate-based microinjec-M. S. Sandhu,* N. J. Doperalski,* D. C. Bolser, † P. J. Reier, ‡ tion. Pigs were sacrificed at 1 week following cellular microinjection and D. D. Fuller* (n = 3) or at 3 weeks for viral microinjection (n = 3). In this series, no procedure-associated mortality was noted. However, one viral microin-*Physical Therapy, University of Florida, Gainesville, FL, USA jection animal was lost at day 15 postop, following the spontaneous †Physiological Sciences, College of Veterinary Medicine, University development of volvulus and subsequent bowel infarction. Sensory and of Florida, Gainesville, FL, USA motor dysfunction was noted in one animal. Histologic analysis has sup- ‡Neuroscience, University of Florida, Gainesville, FL, USA ported our ability to achieve localization to the ventral horn in the spinal cord. The cell graft or viral transgene expression (AAV.GFP) was localized to the ipsilateral cord in the area surrounding the injection site and Following cervical spinal hemisection at C2 (C 2 HS), inspiratory burst amplitude in the ipsilateral (IL) phrenic nerve increases over a was not evident in the contralateral horn or adjacent control tissue.
Intraoperative mortality observed in the first experimental series period of weeks/months. This response is presumed to reflect activation of a monosynaptic bulbospinal pathway that crosses the spinal was not subsequently observed following modification of the intraoperative anesthesia regimen. Morbidity in the first experimental series midline caudal to C2. We examined the neural circuitry underlying this response using neurophysiological methods. Bilateral phrenic was attributed predominately to multiple cord penetrations required for microelectrode recording and subsequent infusion as well as the pres-nerve activity was recorded during quiet breathing (baseline, BL) and respiratory stimulation with hypoxia in five groups of anesthetized ence of physiologic cardiovascular and respiratory-associated movement of the spinal cord. To address this, the subsequent series utilized rats: uninjured and either 2, 4, 8, or 12 weeks following C 2 HS. Motoneuron synchronization was examined via correlation of phrenic inspi-a cervical approach, minimizing respiratory-associated cord movement, and relied upon coordinate-based microinjection into the ventral ratory waveforms recorded IL and contralateral (CL) to injury. The peak-to-noise ratio of the resulting correlogram was calculated to esti-horn to minimize the number of cord penetrations. In the second series, mortality was not observed (excepting the unrelated case of vol-mate the relative strength of IL to CL synchronization (Botteron & Cheney, J. Neurophysiol. 62:1127 -1139 1989) . This ratio was not vulus) and morbidity (n = 1) was attributable to the presence of an epidural hematoma that developed secondary to incompletely con-statistically different between uninjured and C 2 HS rats. However, the peak correlation (a measure of the similarity of IL vs. CL phrenic trolled intraoperative epidural bleeding. Indication of cellular graft viability and viral transgene expression at t = 1 week and t = 3 weeks, neurograms) was persistently reduced after C 2 HS. Analysis of the temporal distribution of the correlogram revealed that the one half width respectively, as well as demonstration of minimized inflammation at the engraftment site, accurate targeting, localized distribution, and im-of the correlogram peak was significantly greater (vs. control) at 2, but not 4-12, weeks postinjury (p < 0.05). The increased one half width proved behavioral outcomes all provide initial preclinical validation of direct, intraparenchymal molecular therapeutics delivery through the is consistent with prolonged conduction time to IL (vs. CL) phrenic motoneurons (Vaughan & Kirkwood, J. Physiol. 503:673-689; 1997). use of a stabilized microinjection platform.
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ABSTRACTS
Finally, a delay in the onset of inspiratory phrenic bursting on the Phenotypic Characteristics of Hybrid Cells Produced by Cell Fusion of Porcine Adrenal Chromatic Cells With Human IL side relative to the CL side was consistently observed after C 2 HS. Preliminary data from experiments using pseudorabies virus to evalu-Mesenchymal Stem Cells ate phrenic motor circuitry after C 2 HS raise the possibility that recovery of IL phrenic output may involve a population of premotor cervical G. Shi, K. Ma, T. Qu, and G. Pappas spinal interneurons. These data suggest that development of the crossed phrenic phenomenon may entail more complex remodeling of Department of Psychology, University of Illinois, Chicago, IL, USA the underlying neural circuitry than currently envisioned.
This work was funded by the Christopher Reeve Paralysis Founda-Transplantation of adrenal chromatic cells (CCs) that release ention and the American Paraplegia Society (D.D.F.) Our results show that these CC and meSC fused hybrid cell population expressed some characteristics of the CC phenotype, suggesting that a Parkinson's disease (PD) is characterized by the progressive neunovel cellular production could be developed by a "reprogramming" rodegenerative loss of dopaminergic neurons in the substantia nigra mechanism through the application of directed cell fusion strategies. pars compacta. While transplantation of fetal dopaminergic neurons Further studies are needed to clarify the long-term fate and therapeutic into the striatum ameliorates behavioral deficits in animal models of values of these hybrid cells.
PD, human clinical trials using these cells have produced equivocal
This study is supported by NIH grants R01 DA 01551 1 to G.D.P. results. This is likely a function of limited cell survival producing uneven engraftment. Coupled with issues of limited cell availability and ethical objections to the use of fetal tissue, fetal tissue transplanta-Apigenin Modulates Microglial Activation Via Inhibition tion for PD is almost impossible. As alternative sources for cell reof Functional CD40 Expression placement therapy, stem or progenitor cells alleviate the problem of cell availability. Using a neural stem cell ( It is well known that most neurodegenerative diseases are associated with microglia-mediated inflammation. Our previous research tion and at 1 and 2 months posttransplantation. Our preliminary results show that intrastriatal transplantation of in vitro differentiated NSC demonstrates that the CD40 signaling is critically involved in microglia-related immune responses in the brain. For example, it is well and mVM in a hemiparkinsonian rat model significantly improved behavior on the apomorphine rotation test to a similar extent and these known that the activation of the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling (JAK/STAT) pathway animals rotated less than the media-injected rats. Histological examination of graft survival as well as engraftment and in vivo differentia-plays a central role in interferon-γ (IFN-γ)-induced microglial CD40 expression. We and others have previously reported that microglial tion of the transplanted cells is currently under way. While the ethical debate on the use of stem cells to treat disease will continue for the CD40 expression is significantly induced by IFN-γ and amyloid-β (Aβ) peptide. Because recent studies have shown that certain flavo-foreseeable future, provision of an unlimited cell source enriched in dopaminergic neurons makes a cell therapy for PD more feasible.
noids possess anti-inflammatory and neuroprotective properties distinct from their well-known antioxidant effects, we investigated the Supported by USF Shimberg award for Parkinson's Disease Research to A.E.W.
flavonoid, apigenin, in modulation of CD40 expression and its signaling in cultured microglia. RT-PCR, Western immunoblotting, and flow cytometry data show that apigenin dose-dependently suppressed IFNγ-induced CD40 expression. In addition, apigenin markedly inhibited IFN-γ-induced phosphorylation of JAK/STAT1. Moreover, apigenin suppressed microglial TNF-α, IL-1β, and IL-6 production stimulated OHDA) to induce a partial lesion of the nigrostriatal system. Immuno-Supported by a University of Cincinnati University Graduate Assistantship and the University of Cincinnati Millennium Fund (C.E.S.). histochemical results 3 months after vector injection reveal efficient gene transfer throughout a large region of the striatum as well as retrograde and anterograde transport to the substantia nigra pars compacta (SNpc) and pars reticulata (SNpr), respectively. Quantitative analysis A Multilevel Analysis of a Methylcellulose-Laminin Scaffold of PTN protein utilizing enzyme-linked immunosorbent assay to Improve Neural Stem Cell Survival in a Traumatically (ELISA) demonstrates that injections of rAAV2/1 PTN/GFP induce Injured Neural Environment significantly higher PTN protein levels than are present in the nontransduced striatum (p < 0.05). Qualitative analysis of tyrosine hy-S. E. Stabenfeldt, H. I. Irons, D. K. Cullen, C. C. Tate, droxylase-immunoreactive (THir) fiber density within the striatum and M. C. LaPlaca revealed that the 6-OHDA lesion area within the striatum of rats injected with rAAV2/1 PTN/GFP was relatively smaller than the stri-Department of Biomedical Engineering, Georgia Institute atal lesion area of rats injected with rAAV2/1 GFP control vector. Stereological analysis of THir SNpc neurons indicated a significant of Technology, Atlanta, GA, USA neuroprotection in rats receiving striatal injections of rAAV2/1 PTN/ GFP compared to those receiving control rAAV2/1 GFP reporter Neural transplantation for traumatic brain injury (TBI) is a promisvector (p < 0.05) with PTN overexpression yielding an approximate ing treatment modality; however, cell transplantation has been limited twofold increase in spared nigral DA neurons compared to controls.
by poor donor cell survival. Recent studies have observed apoptotic Ongoing studies will evaluate the impact of PTN gene transfer on donor cell death following transplantation into an in vivo model of functional outcome measures of drug-induced rotational asymmetry TBI. We hypothesize that a 3D scaffold decorated with bioadhesive and forelimb akinesia. Taken collectively, these data indicate that moieties will enhance the survival of donor cells by decreasing apoptostriatal PTN overexpression can provide significant neuroprotection sis. This study utilized a multilevel approach to examine the impact in an animal model of parkinsonian insult. Continued studies will of a bioactive scaffold (methylcellulose (MC) covalently tethered to provide insight into potential of PTN gene transfer as a therapeutic laminin-1 (LN)) on neural stem cell (NSC) survival in vitro and in strategy to treat PD.
vivo. The first level of evaluation examined the apoptotic activity at Supported by The Michael J. Fox Foundation for Parkinson's Disan acute time point after codelivering NSCs with MC scaffolds into a ease Research (CES) and the University of Cincinnati Millennium mechanically injured 3D neuronal and astrocytic coculture in vitro.
Fund (CES).
This injured coculture has been previously characterized to possess similar components of an in vivo injury environment, including cell death and reactive astrogliosis. By examining acute survival of the NSCs within this in vitro model, the formulations of the MC scaffold can be modified in a high throughput manner prior to in vivo analysis.
Extent of Nigrostriatal Neuroprotection Conferred by High
Briefly, GFP+ NSCs were delivered into injured or uninjured cocul- LN into the injured test-bed, caspase activation of GFP+ cells was Cincinnati, OH, USA reduced to a statistically equivalent level as the control test-bed. These †Department of Molecular and Cellular Physiology, University results suggest that by codelivering the NSCs with MC-x-LN into an injured environment, activation of apoptosis could be reduced. Thereof Cincinnati, Cincinnati, OH, USA fore, this MC-x-LN scaffold was evaluated in a more complex in vivo TBI paradigm. One week after injury, NSCs were injected into the Deep brain stimulation (DBS) has become a popular neurosurgical injury cavity with HBSS or MC-x-LN. Motor behavioral test results treatment for Parkinson's disease (PD). Evidence in rodents suggests for a beam walk task at 8 weeks posttransplant demonstrated that that high-frequency stimulation (HFS) of the subthalamic nucleus NSCs cotransplanted with MC-x-LN had significantly fewer motor (STN) is neuroprotective for substantia nigra pars compacta (SNc) dodeficits compared to NSCs delivered in HBSS. Survival and differentipamine (DA) neurons after 6-hydroxydopamine (6-OHDA) lesioning. ation experiments on the sectioned tissue from this study are currently However, striatal DA terminal density and neurochemistry have yet to ongoing. Collectively, the results from the multilevel analysis suggest be examined. The demonstration that DBS is truly neuroprotective in that MC-x-LN is a material that enhances NSC survival when delivparkinsonian animal models would indicate that this treatment strategy ered to a neural injury environment. could potentially delay the progression of PD. In the present study two groups of male Sprague-Dawley rats were implanted unilaterally with bipolar concentric microelectrodes using extracellular microelectrode Clearance in the Rat Hippocampus During Aging recordings to target the STN. During the same surgical session rats also received unilateral striatal injections of 6-OHDA. Group A then M. L. Stephens,* † ‡ J. E. Quintero, † ‡ F. Pomerleau, † ‡ P. Huettl, † ‡ received continuous HFS (130 Hz, pulse duration of 60 µs) for a peand G. A. Gerhardt* † ‡ riod of 2 weeks. Group B received no stimulation for the same 2-week interval. In order to determine whether HFS of the STN can provide therapeutically relevant neuroprotection of the nigrostriatal system, *Anatomy & Neurobiology, University of Kentucky College stereological analysis of tyrosine hydroxylase-immunoreactive (TH-ir) of Medicine, Lexington, KY, USA neurons in the SNc will be combined with evaluations of TH-ir termi- †Morris K. Udall Parkinson's Disease Research Center of nal density and DA biochemistry of the striatum. The accuracy of STN Excellence, University of Kentucky College of Medicine, targeting will be confirmed by histological analysis. These studies are Lexington, KY, USA ongoing with results to be presented at the meeting. Presently, PD ‡Center for Microelectrode Technology, University of Kentucky patients are not considered for STN HFS unless symptoms have been College of Medicine, Lexington, KY, USA present for 5 years, during which time the disease has progressed significantly. Results from the present study will help determine whether STN HFS should be expanded to treat PD patients in early and moder-L-Glutamate is the predominant mammalian excitatory neurotransmitter. When release and/or uptake are not appropriately regulated, ate stages of the disease. glutamate can persist at elevated extracellular levels and initiate a cas-has been reported to be a crucial signaling element capable of decreasing synaptic plasticity and memory function and modulating neuronal cade of biological events ultimately leading to excitotoxicity. Specifically, glutamate uptake is likely compromised and associated with death, all events that characterize the impact of Aβ in the CNS. On this basis, we hypothesize that aberrant activation of CaN is one mech-neuronal dysfunction in ischemia, epilepsy, and Alzheimer's disease. Approximately 90% of glutamate clearance is executed by transporters anism mediating the cognitive and neurotoxic effects of Aβ. Here we show that Tg2576 transgenic mice, which accumulate Aβ in their brain localized on astrocytes, emphasizing the critical role of glial presence and function in maintenance of normal glutamate concentrations and and display memory deficits reminiscent of AD, exhibit a significant increase in CNS CaN activity. Acute treatment of cognitively impaired brain function. The aging hippocampus displays gliosis and pronounced astrocyte hypertrophy. Hippocampi affected by seizure or Tg2576 mice with the CaN inhibitor FK506 decreased CaN activity to normal levels and restored memory function. Furthermore, we show other insults, such as prolonged hypertension, display similar pathology. Morphological changes do not necessarily predict alterations in that FK506 prevented neural cell death induced by Aβ in a human neuroblastoma in vitro cell model. Collectively, these results indicate function; therefore, any changes in glutamate clearance capacity must be investigated by directly measuring glutamate levels in the extracel-that CaN may be an important component mediating Aβ neurotoxicity and Aβ-promoted cognitive impairments and suggest that CaN inhibi-lular space. Clearance dysregulation may be of critical importance in understanding the positive correlation between increasing age and inci-tors should be further explored as pharmacological tools in AD.
Supported by NINDS grant 1R21NS053986 to G.T. dence of hippocampal-associated disease. Microdialysis has been performed in the aging hippocampus, but slow sampling rates of this methodology have limited the ability to quantify rapid glutamate neu-Functional Repair for CNS Disorders: Integrating Stem Cell rotransmission, possibly masking underlying alterations in glutamate Biology and Material Science uptake due to biological compensatory mechanisms.
Our laboratory has developed a mass fabricated enzyme-based mi-Y. D. Teng,* † E. Y. Snyder, ‡ D. Hogan, † and R. S. Langer § croelectrode array (MEA) and recording system (FAST-16; Quanteon, L.L.C.) optimized for measuring second-by-second glutamate fluctua-*Division of SCI Research, VA Boston Healthcare System, tions in the extracellular space. This technology provides micrometer spatial resolution and subsecond temporal resolution. In vivo clearance Boston, MA, USA mechanisms were investigated by pressure ejection of exogenous glu- †Departments of Neurosurgery and PM&R, Harvard Medical School, tamate (100 µM) into the dorsal and ventral hippocampal subregions Boston, MA, USA (CA1 and CA3, respectively) of young (3-6 months, n = 7), late mid- ‡The Burnham Institute, La Jolla, CA, USA dle-aged (18 months, n = 4), and aged (24 months, n = 5) Fischer 344 §Department of Chemical Engineering, MIT, Cambridge, MA, USA male rats. Clearance of glutamate was recorded on a second-by-second basis. Histology confirmed MEA placement and minimal tissue damage.
We hypothesize that the biology of neural stem cells (NSCs) The length of time required for extracellular glutamate concentramakes them ideally and uniquely suited to reconstructing the damaged tion to peak following exogenous application was significantly shorter central nervous system (CNS) via multimechanistic strategies that are in aged rats (t rise Ϸ 1 s) compared to the CA1 and CA3 regions of often concurrent. They may serve not only as mediators of cell and young and late middle-aged rats (t rise Ϸ 3 s, p < 0.01). Rapid increase circuit reconstitution, but also as vectors for the delivery of molecules of extracellular glutamate in the aged hippocampus, as demonstrated (either as part of their inherent biology or following genetic manipulaby a fast rise time, may indicate a diminished clearance capacity of tion). Based on extensive experience with many neurodegeneration the aged brain. Possible explanations include compromised diffusion models, and buoyed by tangible data in a number of animal models of of glutamate imposed by anatomical crowding of the extracellular injury and disease [including spinal cord injury (SCI), hypoxic-ischespace via gliosis, decreased transporter expression, and/or decreased mic brain injury, and neurodegenerative diseases], we propose to demtransporter function. Rapid progression to elevated extracellular glutaonstrate that NSCs (both of murine and human origin) hold enormous mate concentrations, and the subsequent excitotoxicity that may ensue, promise for a broad range of neurological deficiencies resulting from could be the primary type of glutamate dysregulation contributing to loss of white matter and gray matter after SCI. We believe that these a predisposition in the aging population for hippocampal disease. safe, effective, and multifaceted vehicles may constitute the interface Grant Support: NIA AG00242-09, USPHS MH58414, DA017186, between multiple repair strategies, including tissue engineering, transand NSF DBI-9981807. plantation, gene transfer, viral vectorology, and material science. Our findings to date support these contentions; they suggest not only that the principles that are successful in one neurodegenerative condition Inhibition of Calcineurin Protects From Neural Cell Death may be applicable to other pathologies, but also that progenitor/stem and Memory Deficits Induced by the Alzheimer's Amyloid cells from any solid organ warrant consideration for reconstructing Beta Peptide that respective organ system. We have reported that biodegradable scaffolds impregnated with murine or human NSCs appeared to bridge great gaps in infarcted parenchyma by promoting outgrowth/ingrowth G. Taglialatela,* W. R. Zhang,* D. Hogan, † and K. Dineley † of donor/host fibers. Such findings indicate effective reciprocal relationships between the injured host, stem cells, and the biomaterial. *Department of Neuroscience & Cell Biology, University of Texas Within the spinal cord, the combination of NSCs on such a scaffold Medical Branch at Galveston, Galveston, TX, USA helped enunciate the therapeutic influence NSCs actually have on †Department of Neurology, University of Texas Medical Branch stimulating intrinsic regenerative and/or neuroplasticity mechanisms at Galveston, Galveston, TX, USA within the host. In summary, because NSCs are essentially the first stem cell isolated from a solid organ, their use for repair in prototypi-Alzheimer's disease (AD) is an age-associated dementia charactercal brain and spinal cord injuries may help establish paradigms for ized by memory deficits, loss of CNS neurons, and eventually death. stem cell-based reconstructive strategies in other solid organs. In addi-A prominent neurotoxic event in the AD brain is the presence of extion, the interface between stem cell biology and material science may cess amyloid beta (Aβ) peptide, the result of abnormal processing of serve as a prototype for multidisciplinary strategies against complex the larger amyloid precursor protein (APP). Thus, there is wide conproblems in the nervous and other organ systems. sensus that preventing Aβ toxicity would be a significant advance toward developing an effective cure for AD. Particularly, identifying
The Purine Nucleoside Inosine Is Neurotrophic intracellular signaling elements impacted by Aβ would reveal imporfor Mesencephalic Dopamine Neurons In Vitro tant pharmacological targets to prevent or halt the symptomatic progression of AD. However, this likely effective approach is currently hampered by the scarce knowledge as to the cellular mechanisms me-B. T. Terpstra, K. L. Paumier, N. D. Levine, S. L. Wohlgenant, and C. E. Sortwell diating Aβ neurotoxicity. The protein phosphatase calcineurin (CaN) Department of Neurology, University of Cincinnati, ers like DAT, we determined whether the DAT inhibitor methylphenidate (MPH) could prevent the trophic response induced by MDMA. Cincinnati, OH, USA MPH (2 µM) was added to primary mesencephalic cultures with and without MDMA. MPH had no effect on cultured TH-ir neurons by Parkinson's disease is characterized by a progressive loss of tyroitself, yet completely attenuated the increase in TH-ir neurons associsine hydroxylase (TH)-positive neurons in the substantia nigra pars ated with MDMA co-incubation. This suggests that MDMA, most compacta, resulting in decreased levels of dopamine (DA) in the striawidely known for its putative neurotoxic effects on the adult 5-HT tum. At present there is no clinically viable neuroprotective therapy system, enhances the growth and maturation of developing DA neufor patients with PD and experimental neuroprotective strategies, such rons through its action at DAT. In addition, genomic and real-time as direct infusion or gene transfer delivery of neurotrophic factors, are PCR analyses confirm that MDMA increases the mRNA signal for limited by their invasive nature. Inosine, a purine nucleoside that the production of DAT, suggesting that MDMA induces premature readily crosses the blood-brain barrier (BBB), has been shown to have development of embryonic DA neurons. Further study of the mechaneuroprotective properties against ischemia in vivo (Shen et al., 2005) .
nisms behind MDMAs trophic properties on DA neurons may lead to In the current study, we demonstrate that inosine is neurotrophic for new drug targets and subsequent therapies for neurodegenerative dis-DA neurons in vitro. Mesencephalic cell suspensions derived from eases such as Parkinson's disease. E14 Sprague-Dawley rats were plated at a concentration of 3000 cells/ µl. Cultures were subjected to daily inosine treatment (0.5-4 mM) and evaluated under two separate cell culture paradigms: at plating or 24 h prior to and following a 6-hydroxydopamine (6-OHDA) insult. After FGF-2 and FGFR3 Are Crucial for Nigrostriatal Development the cessation of inosine administration, immunocytochemistry for TH and Rescue After 6-OHDA Lesion: Implications for Combined was performed. At all doses tested, inosine added at plating increased Therapies With Neural Stem Cells in Parkinson's Disease the survival of TH-positive neurons compared to controls (p < 0.0001). Additionally, 2 and 4 mM of inosine augmented survival to a greater M. Timmer,* ‡ K. Cesnulevicius,* C. Winkler, † K. Krampfl, † extent than 0.5 and 1 mM. Treatment with 2 and 4 mM of inosine also G. Nikkhah, ‡ and C. Grothe* protected TH-positive neurons against 6-OHDA administration (p = 0.01). Although preliminary, the current results, combined with ino-*Department of Neuroanatomy, Hannover Medical School, sine's ability to transverse the BBB, indicate that inosine has the po-Hannover, Germany tential to be a noninvasive neuroprotective strategy in animal models of PD. Future experiments will analyze the mechanisms by which ino- †Department of Neurology, Hannover Medical School, sine protects DA neurons in vitro and the ability of inosine to protect Hannover, Germany the nigrostriatal system when administered peripherally to 6-OHDA- ‡Department of Stereotactic Neurosurgery, University of Freiburg, lesioned rats.
Freiburg, Germany Supported by University of Cincinnati Millennium Fund (C.E.S.).
Basic fibroblast growth factor (FGF-2) is involved in the development and maintenance of the nervous system. Exogenous administration of FGF-2 increased dopaminergic (DA) graft survival in different MDMA (Ecstasy) Increases the Growth, Survival, animal models of Parkinson's disease (e.g., cotransplantation). To and Expression of the slc6a3 Gene in Primary study the physiological function of the endogenous FGF-2 system, we Mesencephalic Cultures Via Binding have analyzed the nigrostriatal system of mice lacking FGF-2, mice to the Dopamine Transporter overexpressing FGF-2, and FGF-receptor (R) 3-deficient mice both after development and after 6-hydroxydopamine lesion. FGFR3-defi-V. B. Thompson, E. G. Tolod, K. R. Lynch, C. E. Sortwell, cient mice (+/−) displayed a reduced number of DA neurons compared T. J. Collier, and J. W. Lipton to the respective wild-type. Whereas absence of FGF-2 led to significantly increased numbers of DA neurons, enhanced amount of the growth factor in mice overexpressing FGF-2 resulted in less tyrosine Departments of Psychiatry and Neurology, University of Cincinnati, hydroxylase expression and a reduced DA cell density. The volumes Cincinnati, OH, USA of the substantia nigra were enlarged in both FGF-2(−/−) and in FGF-2 transgenic mice, suggesting an important role of FGF-2 for the establishment of the proper number of DA neurons and a normal sized The club drug MDMA (ecstasy) is a substituted amphetamine that exerts its effects via dopamine (DA) and serotonin (5-HT) transporters substantia nigra during development. Interestingly, the results after lesion were directly opposed to the results after development: signifi-(DAT and SERT). Studies have shown that MDMA damages cortical 5-HT fibers in the adult brain. Conversely, we have previously demon-cantly less DA neurons survived in FGF-2(−/−) mice compared to wild-type mice. Taken together, the results indicate that FGFR3 is cru-strated that prenatal MDMA exposure from embryonic days 14-20 in the rat results in increased branching of dopamine neurons in the stria-cially involved in regulating the number of DA neurons. The lack of FGF-2 seems to be (over)compensated during development but after tum, nucleus accumbens, and prefrontal cortex at postnatal day 21, with no discernable changes to the 5-HT system. In order to determine lesion compensation mechanisms fail. The transgenic mice showed that endogenous FGF-2 protects DA neurons from 6-OHDA neurotox-whether MDMA was directly responsible for the increased growth and survival of dopamine neurons, we utilized E14 primary mesencephalic icity. At present, we try to combine the neuroprotective effects of FGF-2 with neural progenitor cells. We expanded E12-derived neural cell cultures. With this in vitro model, maternal/fetal interactions are bypassed and one can examine the consequences of MDMA applica-stem cells up to 40-fold and subsequently differentiated them into DA neurons. These cells were characterized using morphological, bio-tion directly. We demonstrated that a 4-day MDMA exposure (40 µM) significantly increased the survival (ϳ40%) and outgrowth of tyrosine chemical, molecular biological, and electrophysiological techniques both in vitro and in situ and exhibited all DA characteristics. In addi-hydroxylase-immunoreactive (TH-ir) neurons. Separate control and MDMA-exposed cultures were subjected to full genomic analysis via tion, behavioural tests revealed functional improvements similar to E14-derived cells after transplantation. Recently, we transfected pro-Affymetrix Rat Gene Chips. A statistical examination that controlled for false discovery rates found 181 genes that were significantly al-genitor cells with reporter genes and FGF-2 using different nonviral methods. The transfected cells still differentiated into the desired phe-tered as a result of MDMA exposure. The single greatest fold-change in gene expression was a 4.582-fold increase in the expression of the notype and survived transplantation. Taken together, the combination of an alternative cell source (e.g., progenitor cells) with different DA neuron-specific slc6a3 gene, which encodes for the DAT protein.
These findings were subsequently confirmed by real-time PCR. Be-growth factors could result in better and less variable clinical outcome in neuronal transplantation. cause MDMA's pharmacologic action occurs at monoamine transport-
